rfhg_111139.1

Basic information about the TSS

---

TSS ID: rfhg_111139.1 Species: human Chr: chr8		Start: 129939891 End: 129939899 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4149867,EH38E2668016)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000519540.5:19 GeneID: 51571 HGNC/MGI_ID: HGNC:25216 UniProt_ID: A0A024R9G4 Nearer transcript ids and distances: ENST00000519824.6:59 ENST00000520254.5:73 NM_001353264.2:80 NM_001353244.2:80 NM_001353315.2:80 NM_001353296.2:80 NM_001353300.2:80 NM_001353268.2:80 NM_001353314.2:80 NM_001353299.2:80 NM_001256763.2:80 NM_001353295.2:80 NM_001353298.2:80 NM_001353301.2:80 NM_001353267.2:80 NM_001353265.2:80 NM_001353313.2:80 NM_016623.5:80 NM_001330612.2:80 NM_001353297.2:80 NM_001353266.2:80 ENST00000519070.5:85 ENST00000518344.1:120 ENST00000520204.5:128 AK130372:132 ENST00000522746.5:137 BC017297:137 MF125249:137 ENST00000522941.5:145 ENST00000522250.5:197 BC003599:240 view more...

Gene_name: CYFIP related Rac1 interactor B Gene_symbol: CYRIB Gene_synonyms: BM-009 CYRI CYRI-B Gene_source: HGNC:25216

TATA-Box annotation

---

Distance to TSS:	-84
Nearest PromoterID:	NM_016623
Entrez ID:	51571
Nearest Unigene:	Hs.126941
Nearest Refseq:	NM_016623
Nearest Ensembl:	ENSG00000153310
Gene Name:	CYFIP related Rac1 interactor B
Gene Alias:	BM-009|L1
Gene Type:	protein-coding
CpG%:	0.250000
GC%:	0.777778
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CYRIB p2@CYRIB p3@CYRIB p4@CYRIB p5@CYRIB p6@CYRIB p7@CYRIB p8@CYRIB
Sample		p1@CYRIB	p2@CYRIB	p3@CYRIB	p4@CYRIB	p5@CYRIB	p6@CYRIB	p7@CYRIB	p8@CYRIB
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	60.19	0.78	3.12	1.17	0.00	0.19	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	56.85	0.61	2.63	0.81	0.40	0.20	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	54.40	1.93	2.51	1.16	0.00	0.00	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	42.41	1.46	1.87	0.00	0.21	0.42	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	55.57	0.22	1.57	0.22	0.00	0.00	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	48.06	1.94	2.52	0.39	0.00	0.19	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	61.44	2.83	6.32	0.44	0.22	0.65	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	49.17	1.45	4.60	0.97	0.00	0.73	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	47.66	1.71	3.63	0.64	0.00	0.00	0.00	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	46.95	4.64	3.48	1.74	0.58	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	35.57	1.62	1.62	0.81	0.00	0.81	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	43.50	1.22	2.03	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	14.02	0.48	3.71	4.35	0.64	0.00	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	14.28	0.45	3.76	3.91	0.30	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	15.59	0.88	3.29	6.37	0.00	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	10.56	1.01	2.26	3.52	0.25	0.00	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.51	0.44	2.18	5.68	0.22	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	13.92	0.42	4.22	3.80	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	17.59	2.13	3.73	6.40	0.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	17.75	0.45	4.51	4.21	0.00	0.00	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	15.90	0.27	4.95	4.68	0.40	0.13	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	16.92	1.04	3.63	5.01	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.18	0.78	2.59	5.30	0.13	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	13.83	0.73	3.15	3.88	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	18.58	1.03	4.39	5.42	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	16.46	1.27	4.11	5.70	0.32	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	16.48	1.10	5.49	1.10	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	16.27	0.94	4.01	5.66	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	13.24	0.32	2.10	5.01	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	13.57	0.54	4.71	5.43	0.36	0.00	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	13.82	0.84	3.35	3.98	0.00	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.63	0.00	2.93	4.69	0.39	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	15.41	0.84	2.53	7.60	0.63	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	18.97	0.82	3.46	6.10	0.00	0.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	18.51	0.75	5.24	3.55	0.75	0.19	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	18.40	1.72	3.45	6.52	0.00	0.38	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	16.35	1.23	5.31	4.29	0.20	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	14.31	0.00	2.62	4.84	0.00	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	16.75	0.54	3.24	2.97	0.54	0.27	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	18.48	0.72	5.52	4.08	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.94	0.00	4.23	3.53	0.24	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	17.42	0.88	4.83	4.98	0.15	0.15	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	18.56	1.48	4.22	3.80	0.21	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	16.96	2.62	5.07	4.20	0.17	0.52	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	17.47	0.80	6.83	5.62	0.00	0.00	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	15.35	1.86	4.65	3.72	0.47	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.47	0.96	6.96	2.88	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	16.39	1.19	6.26	2.98	0.00	0.89	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	17.71	0.72	5.03	6.46	0.24	0.24	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	16.38	0.61	5.66	3.44	0.00	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	16.40	2.25	5.33	4.51	0.20	0.41	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	15.57	1.56	5.34	4.00	0.22	0.00	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	0.00	41.98	13.99	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	15.26	2.13	4.26	2.48	0.35	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	11.27	2.65	4.97	3.65	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	27.68	0.84	12.58	11.75	0.84	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	17.45	1.38	7.81	7.35	1.38	0.46	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	18.47	2.27	4.54	2.92	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	19.27	0.96	3.85	3.21	0.64	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	25.15	1.26	6.29	5.97	0.31	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	21.86	2.12	3.53	2.12	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	19.63	1.12	5.61	5.61	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	21.50	3.98	16.72	3.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	17.67	1.02	7.81	5.78	0.00	0.34	0.34	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	22.09	0.32	4.55	6.82	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	20.23	1.77	5.32	4.97	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	16.16	32.33	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	102.67	0.00	39.49	31.59	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	19.99	1.95	3.41	2.93	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	13.39	0.00	3.97	3.47	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	18.76	0.47	5.63	0.94	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	15.90	0.33	5.30	2.32	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	16.40	0.00	1.55	3.09	0.31	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	17.12	0.61	1.53	1.53	0.00	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	7.76	1.11	1.11	1.74	0.16	0.00	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	12.35	0.80	1.93	2.57	0.48	0.16	0.00	0.32
Adipocyte - omental, donor1	11473-119C6	6.49	0.76	1.65	1.78	0.38	0.13	0.00	0.38
Adipocyte - omental, donor2	11474-119C7	6.73	2.24	0.75	1.49	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	8.37	1.00	1.67	3.01	0.00	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	3.83	1.91	0.00	1.28	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	0.00	0.00	1.10	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	3.61	0.00	0.45	1.81	0.00	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	6.95	0.87	0.52	1.91	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	15.06	2.35	4.30	2.54	0.39	0.00	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	11.07	4.89	5.92	1.80	0.26	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	11.15	3.35	2.79	2.51	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	21.16	4.70	1.76	1.76	0.00	0.00	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	65.47	3.46	4.50	5.71	0.80	0.16	0.00	1.93
Adipocyte differentiation, day08, donor2	13023-139D8	18.40	8.07	7.10	2.26	0.32	0.00	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	17.06	6.40	2.67	3.73	1.07	0.00	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	36.17	2.78	2.78	6.12	0.00	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	49.08	3.74	1.25	4.16	0.42	0.42	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	19.84	7.03	7.03	4.02	0.25	0.50	0.25	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	29.45	5.89	2.62	7.53	1.96	0.00	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	64.55	6.09	3.96	3.35	0.91	0.00	0.00	1.83
Alveolar Epithelial Cells, donor1	11510-119G7	12.15	4.20	3.31	2.43	0.88	0.22	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	6.81	3.23	0.72	0.72	0.00	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	0.00	1.20	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	13.49	3.42	3.96	6.84	0.18	0.36	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	1.67	5.02	6.69	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	5.96	1.85	4.93	2.67	0.00	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	12.93	0.23	1.49	4.00	0.11	0.11	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	11.27	0.24	0.98	1.22	0.00	0.24	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.29	3.15	3.15	1.80	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	9.55	2.17	2.60	4.78	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	4.28	0.00	8.56	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.97	3.59	3.29	3.59	0.00	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	0.00	3.79	0.00	3.79	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	2.64	2.64	1.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.15	2.27	4.55	5.85	0.00	0.32	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	11.65	2.43	1.94	2.91	0.49	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	6.53	2.97	1.19	1.78	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.90	6.40	1.88	5.65	0.75	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.98	3.63	1.45	1.45	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	5.02	3.76	1.25	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	10.21	4.78	2.97	5.77	0.49	0.16	0.66	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	1.36	0.00	2.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	8.60	3.32	1.66	4.52	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	4.29	3.21	3.75	3.21	1.07	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.82	2.08	4.72	4.35	0.57	0.00	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	7.75	2.67	1.87	4.01	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	2.93	11.71	2.93	1.95	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.63	1.33	2.49	3.65	0.00	0.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	2.40	1.20	4.80	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	7.08	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	5.49	1.72	2.23	3.77	0.17	0.00	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	7.28	0.97	1.94	3.88	0.00	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.97	3.42	2.66	3.04	0.38	0.76	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	3.63	2.42	6.06	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.69	1.14	1.14	3.42	0.00	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	8.34	2.35	2.99	4.28	0.21	0.21	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.26	2.84	3.87	3.61	0.00	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.04	1.88	1.88	4.69	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	8.04	0.96	1.29	4.50	0.32	0.00	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.85	1.43	1.43	0.71	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	5.85	1.17	0.58	2.92	1.17	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	7.23	3.61	3.31	4.82	0.30	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	5.94	1.19	4.75	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	7.63	1.53	1.53	3.05	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.88	1.53	2.29	4.58	0.00	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	1.27	1.91	2.54	0.00	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	5.18	3.02	1.73	5.18	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.10	1.48	1.27	4.45	0.21	0.42	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.83	2.32	2.32	3.77	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	4.72	0.94	0.00	3.78	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.29	2.88	2.54	3.90	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	2.32	6.95	2.32	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	0.00	4.23	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	6.86	2.14	1.93	4.72	0.64	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	11.43	1.80	2.41	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.02	2.92	2.92	1.46	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	9.88	2.07	2.53	3.45	0.46	0.23	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	2.55	5.10	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	9.41	1.02	2.29	3.56	0.25	0.00	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	8.46	2.68	3.72	4.34	0.21	0.21	0.00	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	6.12	2.14	2.14	2.75	0.61	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	4.78	4.30	4.30	6.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.31	1.77	2.66	3.77	0.22	0.00	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	1.53	0.00	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	7.20	2.77	1.66	1.11	0.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.27	3.71	2.91	2.91	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	8.00	0.73	2.91	4.36	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	19.04	0.61	0.98	4.54	0.37	0.25	0.00	0.25
Astrocyte - cerebellum, donor2	11580-120F5	15.06	1.54	0.51	2.91	0.17	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	8.39	1.05	1.89	2.31	0.21	0.00	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	48.45	1.05	3.83	12.20	0.00	0.70	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	67.62	0.65	5.66	5.82	0.16	0.49	0.16	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	62.65	1.49	3.28	3.28	0.15	0.15	0.00	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	81.66	8.14	15.14	4.93	1.26	0.11	0.11	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	79.18	7.39	14.66	5.39	0.50	0.13	0.00	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	82.39	8.76	11.95	5.12	0.57	0.23	0.34	0.46
Basophils, donor1	12241-129G9	6.28	134.69	40.80	5.49	1.31	0.52	3.14	0.26
Basophils, donor2	12242-129H1	19.84	141.43	59.17	8.30	0.36	4.69	3.97	0.00
Basophils, donor3	12243-129H2	9.41	86.43	37.04	8.08	1.47	1.47	3.97	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	4.53	0.43	2.37	1.29	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	4.57	0.91	0.91	1.37	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	7.17	7.17	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	20.08	14.44	8.79	3.14	0.00	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	16.01	6.86	2.91	2.50	0.21	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	15.43	4.38	4.15	3.91	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	18.17	4.32	8.64	8.10	0.18	0.72	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	56.78	30.09	20.71	4.74	0.82	0.62	1.03	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	52.64	41.46	36.80	8.38	1.86	0.70	0.93	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	72.27	38.37	16.63	10.55	1.60	0.00	0.96	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	10.34	20.68	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	14.65	129.05	68.19	9.02	1.69	1.13	4.51	0.00
CD14+ Monocytes, donor2	11305-117B9	15.59	140.50	57.72	9.84	0.74	1.30	3.71	0.19
CD14+ Monocytes, donor3	11381-118B4	11.20	121.62	63.23	4.61	1.10	1.54	4.39	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	22.93	88.59	45.57	17.27	1.42	0.28	2.26	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	20.47	94.77	36.01	25.02	2.65	0.76	4.17	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	26.63	140.04	43.39	22.35	1.64	1.64	2.96	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	5.78	152.79	85.57	11.27	3.76	2.17	5.35	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	8.75	168.98	58.24	7.85	3.32	2.41	4.53	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	10.19	225.29	78.65	10.19	2.37	1.18	4.50	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.68	135.42	57.08	5.19	1.84	1.00	4.35	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	7.18	160.09	58.79	8.56	3.04	1.66	1.38	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	8.93	156.44	59.50	11.16	2.23	0.74	3.97	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	10.18	114.74	58.94	8.42	1.96	1.57	2.55	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	12.82	130.15	58.40	9.26	0.71	1.25	3.74	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.54	198.04	70.08	19.59	3.92	1.09	3.26	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.85	110.27	51.27	7.02	1.17	0.23	2.58	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	11.62	143.10	48.58	8.98	3.70	1.58	2.64	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	14.42	154.20	44.37	9.98	1.11	3.33	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	6.10	125.25	68.57	9.97	3.42	2.53	5.80	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	6.98	168.22	63.86	11.77	3.99	2.20	2.59	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	9.79	182.80	74.95	12.28	3.54	3.75	1.87	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	8.01	146.42	82.59	8.69	3.43	2.52	5.95	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.11	210.60	64.02	12.67	3.17	1.13	2.49	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	10.91	166.73	67.21	12.22	1.31	0.87	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	8.07	163.55	61.33	9.95	2.42	0.54	5.11	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	15.53	174.98	69.09	10.12	3.49	1.05	3.14	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	15.99	225.14	73.22	14.31	4.21	2.95	2.10	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.51	121.80	70.91	11.76	2.57	1.47	3.12	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	11.98	215.94	76.44	11.62	2.11	2.11	2.11	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	8.34	196.11	65.37	7.46	5.26	1.75	3.51	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	10.29	99.22	54.58	7.50	1.39	1.57	2.62	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	9.29	107.79	43.86	10.78	1.86	1.49	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	12.07	163.82	64.02	15.95	2.59	1.08	1.94	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.73	111.38	57.33	12.28	2.05	2.05	2.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	12.29	170.37	56.33	14.84	2.55	1.16	1.39	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	11.60	193.48	64.26	17.17	3.25	2.09	2.09	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	3.71	264.83	41.41	12.64	2.18	1.09	4.80	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	3.93	227.30	40.66	10.86	1.15	1.15	3.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	1.73	218.35	46.57	11.70	1.52	0.43	3.47	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	0.62	190.60	57.31	10.74	1.09	0.62	4.05	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	0.87	153.34	49.08	10.13	0.52	0.52	3.14	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	2.23	284.51	75.14	11.15	1.34	0.22	3.79	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	4.34	218.68	32.92	11.99	2.30	0.77	3.83	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	5.49	234.93	31.84	12.08	0.88	0.44	3.29	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	2.53	274.34	44.21	16.42	1.26	0.84	6.11	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	10.16	38.61	52.84	6.10	2.03	0.00	2.03	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	13.56	42.03	75.26	4.07	1.36	0.00	4.07	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	13.46	38.32	65.24	12.43	2.07	0.00	3.11	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	10.66	47.97	71.96	10.66	1.07	1.07	1.60	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	14.47	45.03	76.66	6.97	0.54	1.61	1.61	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	21.06	41.41	57.56	4.91	0.70	2.11	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	18.82	36.86	64.32	9.41	0.78	0.00	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	10.55	52.73	71.19	1.32	0.00	2.64	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	18.08	59.18	50.96	5.75	0.00	0.82	0.00	1.64
CD19+ B Cells, donor2	11624-122B4	30.47	39.90	37.00	6.53	1.45	0.73	2.18	0.73
CD19+ B Cells, donor3	11705-123B4	21.20	46.44	41.40	3.53	0.50	0.50	2.02	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	36.37	0.81	2.83	0.40	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	31.16	2.80	2.40	0.00	0.00	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	32.13	14.06	3.01	6.02	0.00	0.00	1.00	2.01
CD34+ Progenitors, donor2	11625-122B5	45.51	41.57	14.61	4.49	1.12	2.25	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	74.02	37.58	11.27	7.89	1.50	0.00	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	69.22	41.94	18.26	12.63	1.13	0.45	0.23	1.13
CD4+ T Cells, donor1	11225-116C1	52.13	40.35	47.85	5.36	1.07	1.07	1.79	0.00
CD4+ T Cells, donor2	11306-117C1	43.48	42.87	56.34	2.45	1.22	3.67	4.29	0.00
CD4+ T Cells, donor3	11382-118B5	32.02	49.71	46.66	4.27	0.91	1.22	2.44	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	28.08	61.00	29.86	12.00	2.30	2.30	1.02	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	32.34	63.79	33.91	12.35	2.02	1.57	1.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	22.42	59.79	35.36	12.94	2.01	0.86	1.44	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	18.02	36.51	54.05	3.79	1.42	3.79	1.90	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	15.45	34.41	59.70	4.21	0.70	2.11	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	52.74	46.15	0.00	0.00	3.30	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	29.05	40.46	22.69	9.25	1.01	1.88	1.45	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	45.75	55.58	31.86	9.83	1.53	0.68	1.19	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	41.27	51.10	31.27	7.90	1.45	1.29	1.13	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	22.41	60.07	36.31	4.03	0.90	1.34	1.79	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	20.26	60.79	55.20	4.19	0.35	3.14	1.75	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	18.04	71.72	64.68	4.84	0.00	3.52	2.20	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	26.99	53.55	24.03	13.91	2.11	2.11	1.26	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	35.11	55.89	36.98	11.84	2.49	1.87	1.87	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	30.74	57.47	29.40	14.37	0.67	0.33	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	18.76	47.04	47.04	6.80	1.36	2.99	1.36	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	32.16	40.73	48.24	6.97	0.00	2.68	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	23.31	30.48	60.97	5.38	0.00	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	49.51	60.64	34.86	12.42	1.48	0.93	2.23	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	44.41	58.49	32.93	9.10	2.17	2.60	1.95	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	36.78	83.64	40.35	14.92	1.89	3.57	1.68	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	18.71	40.95	57.13	6.57	1.52	3.54	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	22.10	43.33	61.09	8.23	1.30	5.20	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	26.15	42.27	63.19	6.54	1.31	6.10	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	21.28	67.30	78.19	9.40	0.99	3.46	3.46	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	25.85	57.24	71.09	6.46	0.92	7.39	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	15.35	47.46	82.35	11.17	0.00	5.58	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	14.40	83.36	53.17	12.18	0.83	9.97	2.22	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	20.86	90.79	58.40	9.82	0.98	7.85	1.23	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	23.10	89.32	70.84	7.70	1.54	6.16	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	20.41	69.83	100.63	9.31	0.72	3.58	3.58	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	24.93	88.64	128.80	8.31	4.15	4.15	4.15	0.00
CD8+ T Cells, donor1	11226-116C2	24.88	53.04	67.44	6.22	0.00	4.26	2.62	0.33
CD8+ T Cells, donor2	11307-117C2	25.53	64.20	59.69	7.88	1.50	2.63	4.51	0.00
CD8+ T Cells, donor3	11383-118B6	30.30	59.33	57.32	5.05	0.25	3.28	3.53	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	33.49	2.52	5.73	1.61	0.23	0.23	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	31.15	1.20	5.51	1.68	0.24	0.96	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	34.47	1.64	6.02	2.46	0.00	0.82	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	25.52	0.60	7.21	2.70	0.30	1.50	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	30.96	1.92	4.56	0.96	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	29.79	2.05	5.68	1.82	0.00	0.68	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	33.03	1.52	6.52	1.09	0.22	0.65	0.22	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	41.85	3.42	4.74	0.79	0.00	0.00	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	35.88	3.28	6.80	0.70	0.00	0.23	0.47	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	41.96	1.81	6.94	1.21	0.00	0.60	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	39.51	1.16	5.52	1.16	0.00	0.29	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	37.83	2.40	5.06	1.33	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	23.64	2.63	6.57	2.19	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	25.05	2.28	5.92	0.91	0.00	0.91	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	39.53	0.00	4.48	1.49	0.00	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	31.33	3.96	7.20	2.16	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	33.38	2.88	4.32	1.44	0.00	0.58	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	28.28	2.36	10.13	0.71	0.00	0.71	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	42.78	1.58	6.34	1.90	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	39.06	1.85	7.38	0.62	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	34.94	1.28	5.13	0.96	0.32	0.64	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	38.63	3.44	3.82	0.76	0.00	0.76	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	40.99	0.79	5.12	0.79	0.00	0.00	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	35.55	1.51	4.54	0.76	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	24.09	2.41	1.61	2.41	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	31.47	0.70	6.29	2.10	0.00	1.40	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	26.05	3.01	4.01	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	9.14	7.31	1.83	3.66	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	16.30	0.99	0.99	4.45	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	14.31	1.58	3.16	3.79	0.21	0.11	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	19.41	0.35	0.00	1.39	0.00	0.00	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	7.46	0.00	1.07	0.36	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	9.44	0.34	0.91	1.02	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	22.38	0.00	1.79	2.69	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	13.75	0.00	0.00	0.00	0.00	0.00	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	50.38	2.07	5.05	6.08	0.11	0.23	0.00	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	33.56	2.14	5.13	5.34	0.21	0.21	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	34.60	3.81	5.04	4.69	0.53	0.35	0.09	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	40.90	9.45	8.44	7.43	0.83	0.28	0.28	0.37
Corneal Epithelial Cells, donor1	11526-119I5	6.15	1.32	2.63	1.54	0.00	0.44	0.00	0.44
Corneal Epithelial Cells, donor2	11606-120I4	10.24	1.14	2.28	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	8.69	2.56	2.30	2.05	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	9.74	110.94	46.39	6.60	3.14	0.50	2.64	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	9.15	93.05	50.15	5.05	0.63	0.63	1.58	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	120.77	31.06	0.00	0.00	0.00	6.90	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	3.24	78.29	40.71	5.08	1.30	0.76	1.62	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	19.13	97.37	67.64	23.23	4.78	4.78	2.05	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	30.68	152.12	79.65	28.73	5.88	3.26	3.92	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	21.78	141.80	60.49	27.58	4.84	6.78	1.45	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	17.68	3.34	3.67	2.50	0.33	0.17	0.33	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	7.04	4.69	2.35	1.17	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	13.86	6.22	1.70	2.26	0.00	0.28	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	15.73	7.47	3.93	1.97	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	8.14	3.78	1.16	2.33	0.00	0.29	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	16.00	6.59	4.00	2.12	0.47	0.24	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	14.73	2.98	1.40	1.93	0.00	0.00	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	7.54	5.54	2.88	2.44	0.22	0.00	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	8.82	8.82	4.26	4.56	0.00	0.00	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.10	5.64	3.38	3.10	0.28	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	10.10	5.05	1.49	1.78	0.00	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	14.06	3.12	2.08	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	7.66	4.40	1.42	0.57	0.28	0.14	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	20.81	8.80	4.00	2.40	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	6.29	1.05	1.57	1.05	0.52	0.00	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	34.66	10.19	5.59	4.47	0.37	0.37	0.62	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	24.77	9.56	2.61	3.91	0.00	0.00	0.87	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	35.91	11.24	4.64	1.71	0.24	0.12	0.49	0.24
Endothelial Cells - Vein, donor1	11267-116G7	13.65	5.69	0.00	1.14	0.00	0.00	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	16.07	2.79	1.40	0.70	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	19.00	7.22	4.24	1.26	0.47	0.31	0.00	0.00
Eosinophils, donor1	12244-129H3	30.49	213.46	182.96	0.00	0.00	15.25	15.25	0.00
Eosinophils, donor2	12245-129H4	75.91	1937.41	658.45	46.21	36.31	21.45	70.96	1.65
Eosinophils, donor3	12246-129H5	28.53	1287.62	449.42	35.67	39.24	17.83	57.07	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	6.35	0.98	2.69	0.49	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	2.08	0.00	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	12.73	0.82	1.64	1.23	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.71	0.77	1.42	2.41	0.11	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.22	1.63	1.41	2.49	0.33	0.11	0.00	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	19.89	1.33	2.43	2.67	0.12	0.12	0.00	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	11.46	1.50	4.50	4.50	0.14	0.00	0.14	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.70	2.00	1.90	2.74	0.21	0.11	0.11	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	13.17	0.79	0.26	4.22	0.53	0.26	0.00	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	15.95	2.99	3.65	2.99	0.33	0.33	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	16.33	2.72	1.81	3.18	0.45	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	11.37	4.55	3.79	0.76	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	6.47	2.37	2.68	2.52	0.16	0.16	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	19.10	2.12	3.64	3.64	0.30	0.00	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	14.97	2.03	2.66	3.43	0.00	0.13	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	17.43	3.34	2.27	2.58	0.00	0.30	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	6.57	0.80	0.67	2.41	0.00	0.13	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	5.18	0.00	1.73	2.59	0.43	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	19.04	0.00	1.46	4.39	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	8.30	0.00	0.00	0.23	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	8.65	0.68	2.20	5.94	0.00	0.17	0.00	0.17
Fibroblast - Dermal, donor1	11269-116G9	6.57	0.00	0.47	2.11	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	11.79	3.30	0.47	0.94	0.00	0.00	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	9.31	0.24	1.45	1.69	0.00	0.00	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	24.87	0.34	0.68	1.24	0.00	0.00	0.11	0.34
Fibroblast - Dermal, donor5	11454-119A5	31.40	0.35	1.22	1.74	0.17	0.00	0.00	0.35
Fibroblast - Dermal, donor6	11458-119A9	37.84	0.49	1.14	1.95	0.00	0.00	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	18.32	0.62	2.50	3.54	0.21	0.00	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	17.55	1.83	2.10	1.83	0.00	0.00	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	34.53	2.11	4.88	4.88	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor3	11394-118C8	9.96	0.48	1.93	2.71	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	9.35	1.04	1.04	3.12	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	11.63	0.70	0.70	1.41	0.00	0.00	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	29.15	1.25	2.03	1.87	0.00	0.16	0.00	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	27.59	1.35	1.76	2.16	0.27	0.00	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	14.12	1.41	1.06	3.18	0.35	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	22.67	1.17	1.90	3.51	0.00	0.00	0.00	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	22.63	1.64	2.05	1.77	0.41	0.00	0.00	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	37.08	1.65	1.86	1.97	0.44	0.00	0.11	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	13.79	0.73	1.61	4.99	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	1.36	0.00	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	26.86	0.00	0.00	2.98	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	16.88	0.21	2.11	1.90	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	9.16	0.83	0.00	2.50	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	0.00	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.68	0.00	0.28	0.56	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	8.12	0.00	2.84	0.00	0.41	0.00	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	31.42	0.19	4.07	5.63	0.19	0.00	0.00	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	47.93	0.61	2.58	3.19	0.00	0.15	0.00	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	26.62	0.92	2.14	3.06	0.00	0.00	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	16.41	1.14	2.67	2.67	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	14.04	1.35	3.24	2.16	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	12.76	1.04	1.97	1.74	0.00	0.00	0.00	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	24.87	3.76	4.64	3.21	0.44	0.22	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	7.72	0.61	1.02	1.02	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.02	0.00	0.67	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	9.88	1.19	1.98	0.40	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	16.87	1.39	1.79	3.37	0.00	0.20	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	10.83	0.36	1.78	2.66	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	7.29	0.99	2.96	1.38	0.20	0.00	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	15.34	0.60	1.20	1.50	0.60	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	14.47	0.65	0.54	3.35	0.00	0.00	0.00	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	10.38	1.01	1.27	5.57	0.25	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	9.52	0.49	1.97	3.45	0.00	0.16	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	20.65	1.60	3.01	3.01	0.00	0.00	0.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	18.59	1.31	1.31	3.01	0.00	0.10	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	19.65	1.51	2.12	0.91	0.00	0.00	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	12.10	0.08	1.82	2.73	0.08	0.00	0.08	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	11.11	0.00	0.85	5.81	0.00	0.17	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	10.84	1.97	2.63	3.94	0.33	0.00	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	18.32	1.92	1.28	4.05	0.11	0.21	0.00	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	22.27	3.71	3.37	4.22	0.34	0.00	0.17	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	10.98	0.63	1.88	2.98	0.00	0.16	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	22.16	22.16	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	39.22	12.20	5.23	6.97	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	22.36	14.74	13.35	9.01	2.08	0.69	0.35	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	22.90	9.37	13.79	7.03	0.26	1.04	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	30.92	16.61	13.29	5.88	2.04	0.26	0.51	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	79.62	6.89	0.77	3.83	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	84.86	6.38	5.10	3.19	0.64	0.00	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	128.37	9.13	13.69	5.42	1.14	1.43	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	96.52	1.38	3.86	6.07	0.83	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	74.66	1.83	4.11	3.88	3.88	0.68	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	100.06	5.55	10.90	4.36	1.19	0.59	0.40	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	108.11	0.53	3.97	1.59	0.53	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	89.69	1.30	3.26	5.22	0.65	0.00	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	114.98	6.19	8.84	7.08	0.00	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	48.61	1.70	3.53	4.24	0.42	0.85	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	52.83	2.71	5.05	5.54	0.25	0.25	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	45.40	4.57	3.76	4.57	0.81	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	50.42	4.83	11.15	5.20	0.62	0.74	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	54.26	6.64	10.80	7.61	0.83	0.97	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	44.73	6.91	8.95	6.71	1.02	0.61	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	41.53	5.93	11.87	5.25	0.00	1.83	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	40.61	6.85	14.82	7.22	0.62	1.62	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	50.05	7.65	13.33	4.81	0.22	1.53	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	43.73	1.77	10.93	4.43	0.30	0.89	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	43.87	2.70	7.15	6.68	0.64	0.48	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	46.25	4.47	7.37	6.03	0.67	0.45	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	44.36	2.82	6.25	5.85	0.40	0.40	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	49.71	2.88	6.45	6.45	0.34	0.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	57.02	4.88	10.91	5.76	0.62	0.98	0.18	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.04	1.87	8.01	8.53	0.73	0.31	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	36.72	1.88	5.64	7.34	0.34	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	37.40	2.21	6.09	7.19	0.11	0.66	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	48.75	3.74	7.49	7.15	0.67	0.75	0.25	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	44.10	3.68	6.13	6.53	0.00	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	36.52	2.89	7.63	8.66	0.00	0.00	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	35.74	1.84	6.11	10.38	0.12	0.58	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	37.02	3.84	6.17	5.17	0.33	0.33	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	27.55	2.87	5.51	5.73	0.00	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	30.26	1.60	6.15	8.61	0.37	0.86	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	37.93	1.78	6.16	5.02	0.49	0.16	0.32	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	24.70	4.17	4.49	7.38	0.32	0.00	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	25.87	2.18	5.97	6.44	0.09	0.19	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	22.78	2.21	8.54	3.48	0.79	0.32	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	25.85	3.34	5.17	4.56	0.61	0.30	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	28.75	2.09	5.85	4.70	0.31	0.42	0.00	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	21.52	1.54	7.25	5.49	0.00	0.66	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	32.54	2.52	5.05	6.73	0.56	0.00	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	22.04	2.13	7.50	5.56	0.74	0.46	0.19	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	23.53	2.14	9.09	4.55	0.53	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	28.61	3.83	7.34	3.52	0.31	0.15	0.15	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	21.11	2.20	7.77	6.48	0.39	0.52	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	21.96	1.63	7.86	4.61	0.27	0.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	21.20	1.47	8.85	4.61	0.74	0.37	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	18.64	2.19	7.46	5.48	0.00	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	12.89	0.99	9.92	8.93	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	18.60	2.90	6.73	4.75	0.13	0.26	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	15.54	1.01	4.44	4.64	0.20	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	20.33	1.52	4.32	7.88	0.00	0.00	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	85.60	3.98	2.19	5.57	0.20	0.60	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	56.70	1.54	3.54	3.39	0.15	0.46	0.15	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	83.88	2.05	4.09	4.50	0.00	0.00	0.00	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	81.05	0.94	4.38	2.82	0.31	0.00	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	67.25	2.83	2.26	2.54	0.28	0.28	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	104.23	3.69	3.69	1.84	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	84.14	4.95	7.42	2.47	0.00	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	82.39	7.35	5.80	5.42	0.77	0.00	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	104.29	12.84	1.60	6.42	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	85.20	6.96	10.43	1.74	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	70.30	5.86	3.25	5.21	0.65	0.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	67.54	4.94	4.53	2.47	0.82	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	66.65	3.33	3.33	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	67.12	2.80	3.36	4.19	0.84	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	64.06	4.58	3.27	4.25	0.98	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	78.85	0.00	2.52	1.68	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	68.07	2.86	5.41	4.77	0.32	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	68.27	3.06	5.77	1.36	1.02	0.68	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	71.00	2.09	10.44	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	69.30	4.01	7.45	3.44	0.57	0.00	0.00	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	52.68	1.48	2.37	4.14	0.30	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	57.60	1.69	5.08	3.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	65.44	3.73	3.31	3.31	0.41	0.41	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	77.32	2.76	4.37	4.37	0.23	0.23	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	84.30	0.00	10.54	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	63.43	2.31	3.46	4.61	0.38	0.00	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	60.96	3.26	2.93	3.59	0.33	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	72.90	3.34	4.01	3.34	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	61.64	4.24	4.24	8.86	0.00	0.00	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	78.05	4.79	4.79	5.82	0.00	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	72.06	0.00	7.45	14.91	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	62.76	2.83	2.36	7.08	0.94	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	63.37	1.81	2.41	6.03	0.00	1.21	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	69.69	5.09	5.09	3.56	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	66.21	2.79	3.19	7.98	0.40	1.20	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	64.14	1.97	3.95	8.39	0.99	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	73.19	5.90	7.08	8.26	1.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	60.68	0.58	4.67	8.17	0.58	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	61.00	2.19	3.07	10.97	0.00	0.44	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	50.01	2.54	7.63	3.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	52.53	1.19	4.78	2.98	0.00	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	48.04	2.91	1.94	2.43	0.00	0.49	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	6.85	0.00	0.00	0.00	0.00	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.98	1.25	0.42	2.49	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	16.87	0.00	4.50	2.25	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	5.39	1.90	1.90	2.85	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.51	0.84	2.92	2.51	0.00	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	44.21	5.11	9.52	6.15	0.81	0.58	0.46	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	43.38	3.54	8.44	5.57	0.51	1.01	0.00	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	45.50	4.10	7.51	3.64	0.91	0.46	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	43.07	4.92	6.34	6.67	0.22	0.55	0.00	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	47.50	5.37	6.45	4.94	0.00	0.86	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	46.07	4.52	5.17	4.52	0.00	0.43	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	41.35	4.98	7.60	5.48	0.37	0.37	0.12	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	34.14	4.12	6.86	3.95	0.69	1.03	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	38.12	3.84	6.41	3.20	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	8.95	15.11	1.12	2.80	0.00	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	4.76	0.87	0.87	0.43	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	2.64	0.00	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	6.35	1.41	0.35	2.12	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	3.63	0.73	0.73	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	13.46	1.22	2.10	3.32	0.00	0.17	0.17	0.17
Hepatocyte, donor1	11523-119I2	25.42	2.42	1.21	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	28.01	5.39	6.46	1.08	0.00	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	29.45	9.20	2.45	0.61	0.61	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	160.56	41.77	27.41	15.01	1.96	1.31	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	25.17	1.92	6.47	7.87	0.35	0.52	0.00	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	20.44	2.61	3.57	6.04	0.14	0.27	0.27	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	0.00	6.37	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	0.00	8.31	4.15	0.00	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	0.00	2.50	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	11.87	23.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	28.19	2.56	5.13	2.56	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	0.00	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	3.25	11.37	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	13.34	1.67	5.00	3.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	0.00	0.00	7.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	22.50	1.32	3.97	3.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	15.52	1.11	3.33	4.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	14.49	1.26	8.19	5.04	0.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	15.47	3.09	10.83	1.55	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	18.74	1.29	7.11	3.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	9.66	6.44	3.22	3.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	23.90	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	17.11	0.81	7.33	5.70	0.81	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	10.08	1.26	6.30	2.52	0.42	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	23.31	3.21	4.02	4.02	0.00	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	17.54	0.92	4.62	4.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	21.71	0.94	4.72	2.83	0.47	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	11.79	2.72	8.16	2.72	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	18.29	3.23	6.46	9.69	0.00	2.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	24.14	1.27	6.35	2.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	14.03	1.28	4.46	3.83	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	5.47	3.65	5.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	12.85	2.86	5.00	6.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	0.00	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	16.36	1.85	6.48	3.70	0.00	0.31	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	17.56	0.00	5.27	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	3.14	6.29	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	29.90	1.39	3.48	4.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	33.20	2.21	0.00	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	3.24	3.24	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	19.18	2.62	3.49	2.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	2.25	11.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	0.00	3.48	6.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	11.73	2.13	3.20	8.53	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	13.85	1.39	8.31	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	8.55	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	9.20	1.84	7.36	4.60	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	9.52	2.11	4.23	2.11	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	14.20	4.98	4.73	6.69	1.14	0.49	0.24	0.33
Keratinocyte - epidermal, donor2	11349-117G8	16.98	1.76	2.93	4.69	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	34.74	4.64	11.07	6.91	0.57	1.04	0.00	0.09
Keratinocyte - oral, donor1	11251-116E9	44.95	6.02	17.14	16.01	1.14	1.93	0.45	0.00
Keratocytes, donor1	11527-119I6	10.31	0.34	0.69	1.72	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	7.03	0.00	3.52	2.34	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	12.84	0.20	2.77	4.74	0.20	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	61.54	6.59	10.99	4.40	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	19.42	2.16	2.16	3.24	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	39.21	1.15	6.92	10.50	0.35	0.23	0.00	0.23
Lens Epithelial Cells, donor3	11690-122I7	18.06	2.02	4.44	7.37	0.10	0.20	0.10	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	18.14	5.93	4.27	2.73	0.12	0.24	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	11.16	3.07	1.67	1.40	0.28	0.00	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	21.41	6.77	2.83	2.36	0.16	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.60	3.76	0.54	2.15	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	13.24	3.47	1.89	0.95	0.00	0.00	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	12.83	3.13	1.94	0.97	0.00	0.00	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	23.39	4.92	1.64	2.87	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.31	3.29	1.77	0.76	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.82	3.10	2.11	0.70	0.28	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	13.45	5.93	3.56	1.19	0.00	0.40	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	15.12	4.07	3.30	1.36	0.39	0.00	0.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.48	1.30	1.48	0.19	0.00	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	13.24	5.92	3.83	1.05	0.00	0.70	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.73	5.96	3.34	1.43	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	10.85	3.57	1.79	0.82	0.27	0.27	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	17.55	6.16	2.46	1.54	0.00	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.92	3.12	0.94	0.00	0.00	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.08	2.93	2.20	0.91	0.00	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	16.46	3.95	1.65	3.62	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	8.79	4.10	1.17	0.88	0.00	0.29	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	9.71	1.49	1.74	0.50	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	16.49	6.30	2.42	0.48	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	14.54	6.19	1.89	2.42	0.27	0.54	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	16.20	3.33	2.88	2.42	0.30	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	11.92	2.59	0.52	2.59	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.54	6.49	2.09	0.63	0.21	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	12.03	3.31	2.71	1.35	0.00	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.01	4.13	0.69	1.38	0.69	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.05	3.39	2.63	2.45	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.97	3.18	2.12	0.95	0.11	0.11	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	13.57	7.75	4.36	1.94	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.57	2.98	2.98	0.00	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	10.41	3.22	2.11	1.24	0.12	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	16.29	6.29	2.59	1.48	0.37	0.37	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	17.54	4.20	3.46	0.25	0.00	0.74	0.25	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.70	3.44	1.37	1.37	0.00	0.27	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	20.91	4.82	2.57	2.89	0.64	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	18.56	5.78	3.96	0.91	0.00	0.00	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	19.60	5.46	3.78	2.80	0.14	0.14	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	14.22	8.18	1.42	1.78	0.36	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.79	3.39	0.97	0.97	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.38	2.33	0.62	0.31	0.16	0.00	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	14.32	6.80	3.22	2.15	0.36	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.43	4.57	2.61	0.98	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	7.77	1.88	1.41	0.94	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	12.25	7.55	4.46	2.48	0.00	0.00	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	8.20	2.56	2.82	0.26	0.26	0.26	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.95	3.88	1.79	0.90	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	33.99	9.06	9.06	18.13	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	29.92	9.97	15.34	9.97	3.07	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	24.49	8.91	2.97	6.68	0.00	0.74	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	30.89	9.73	10.16	8.04	1.27	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	27.43	7.74	14.07	9.14	1.41	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	21.48	11.21	8.41	8.41	1.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.22	8.76	9.79	7.21	0.00	1.03	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	29.74	7.14	11.89	3.57	0.00	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	30.31	6.11	9.27	9.73	2.04	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	36.06	8.43	6.69	12.21	1.16	0.29	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	36.46	7.20	9.45	9.45	1.35	0.00	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	32.25	9.75	10.16	11.25	3.12	0.68	0.14	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	30.30	7.70	7.19	8.73	2.05	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	35.64	11.29	12.70	7.06	2.12	1.41	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	25.32	6.66	5.33	6.66	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	35.15	13.24	8.15	16.81	1.53	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	33.08	8.54	12.01	14.67	1.60	0.53	0.53	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	36.28	10.01	9.64	9.64	1.13	0.76	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	37.43	12.27	8.59	9.20	0.61	1.23	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	37.51	12.23	11.42	11.42	1.63	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	36.44	7.08	9.37	13.12	1.04	0.21	0.42	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	44.84	10.93	10.65	12.05	2.52	0.56	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	50.49	11.33	9.27	7.21	1.03	1.03	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	37.16	7.55	10.16	8.71	1.45	0.58	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	41.25	11.06	13.45	11.96	1.20	0.60	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	42.60	7.75	19.36	8.85	0.55	0.55	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	34.29	12.02	11.67	12.37	0.71	0.71	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	45.73	12.17	11.43	7.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	36.84	5.76	14.97	12.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	40.68	7.68	8.44	9.21	1.15	0.38	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	37.36	10.76	15.85	6.79	0.00	0.00	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	22.97	9.03	13.95	5.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	36.60	14.91	12.65	11.30	1.81	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	32.32	12.21	10.77	7.90	0.72	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	34.36	5.23	8.96	11.95	0.75	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	35.30	7.06	11.15	11.89	1.86	1.11	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	37.04	11.20	11.63	11.20	2.15	0.43	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	35.96	8.56	7.71	9.42	0.00	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	32.98	8.66	10.99	9.33	1.00	0.33	0.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	37.41	8.45	9.05	10.86	3.02	0.60	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	24.17	3.55	5.69	9.95	0.71	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	26.47	8.25	7.91	7.56	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	30.59	8.59	10.73	8.59	0.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	27.61	6.06	12.79	10.10	1.35	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	37.41	9.63	11.48	12.59	1.48	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	47.68	9.30	19.77	15.12	3.49	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	32.79	8.46	10.58	9.52	4.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	31.21	12.40	13.61	12.80	1.60	0.80	0.40	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	37.07	10.18	15.26	8.00	2.18	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	39.09	13.80	13.03	8.43	1.53	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	30.09	14.31	9.37	8.88	1.48	0.99	0.49	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	32.93	11.29	7.53	8.47	1.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	34.69	10.06	12.07	9.05	1.51	1.51	0.00	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	33.35	8.11	15.32	10.81	2.70	1.80	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	24.10	15.49	10.33	6.88	3.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	29.84	9.80	13.81	9.35	1.34	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	33.24	9.78	10.56	9.78	1.96	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	25.73	13.85	9.90	10.56	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	44.63	11.42	14.01	8.30	1.04	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	40.26	10.06	14.00	13.13	1.31	0.00	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	36.90	13.98	7.83	8.95	0.56	0.00	0.00	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	35.33	13.69	10.16	14.13	1.77	0.00	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	33.17	14.27	11.96	13.11	1.16	0.39	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	43.04	12.15	12.15	10.13	1.52	1.01	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	39.41	10.09	16.34	10.09	1.44	1.44	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	39.36	10.34	8.35	11.53	1.59	0.40	0.40	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	41.32	17.01	11.54	10.94	0.00	1.22	1.82	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	24.21	8.99	4.15	12.45	0.00	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	45.98	11.02	12.92	11.78	1.52	1.90	0.00	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	48.03	14.46	15.49	9.30	2.07	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	33.86	13.30	4.23	7.26	2.42	1.21	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	46.27	11.73	11.41	10.46	1.27	0.63	0.63	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	52.24	14.93	7.46	9.60	0.53	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	44.82	13.22	6.32	10.92	0.00	1.72	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	52.45	12.34	11.83	7.20	1.54	0.51	0.00	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	40.32	10.61	19.81	7.78	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	39.16	17.59	7.94	10.78	2.27	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	42.85	7.49	15.39	11.65	2.50	0.42	0.42	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	47.77	13.31	14.09	6.26	1.57	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	45.10	13.78	6.26	8.35	1.25	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	40.89	10.69	18.12	12.08	4.18	0.00	0.00	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	47.50	9.37	15.39	8.70	1.34	1.34	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	46.51	12.83	10.69	7.48	0.53	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	59.40	8.89	23.03	8.89	3.64	1.21	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	54.15	12.85	14.68	14.68	2.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	44.46	8.89	8.00	10.67	2.67	2.67	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	47.30	13.11	11.97	6.84	1.14	0.57	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	55.98	8.44	15.34	5.37	3.07	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	44.87	10.40	6.57	8.75	2.19	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	43.65	10.69	15.15	14.25	2.67	0.00	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	58.23	10.14	10.92	13.52	0.78	0.78	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	42.44	13.26	7.29	18.57	2.65	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	54.04	12.47	6.24	12.47	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	7.75	121.71	29.17	19.83	5.93	0.68	2.73	0.00
Macrophage - monocyte derived, donor2	11313-117C8	2.02	56.52	46.98	9.54	0.92	0.37	1.47	0.18
Macrophage - monocyte derived, donor3	11389-118C3	3.54	108.93	41.81	10.88	2.23	0.79	2.36	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	26.02	9.56	12.74	7.97	1.06	0.53	1.59	0.53
Mallassez-derived cells, donor2	11929-125I3	14.58	13.15	15.69	7.29	0.79	2.54	0.32	0.32
Mallassez-derived cells, donor3	11930-125I4	20.71	9.03	13.76	10.56	0.69	1.39	0.14	0.42
Mammary Epithelial Cell, donor1	11273-116H4	45.04	3.19	6.78	7.47	0.30	0.60	0.10	0.10
Mammary Epithelial Cell, donor2	11350-117G9	35.61	7.24	6.08	9.56	0.00	1.16	1.16	0.29
Mammary Epithelial Cell, donor3	11422-118F9	15.96	4.49	6.73	2.99	0.50	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	59.66	10.17	10.17	8.14	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	25.74	8.11	14.17	13.19	0.76	0.32	0.65	0.00
Mast cell, donor2	11565-120D8	16.64	11.89	9.51	12.78	1.19	0.00	0.59	0.30
Mast cell, donor3	11566-120D9	20.94	19.14	12.61	9.68	1.13	0.23	0.45	0.23
Mast cell, donor4	11567-120E1	17.73	10.81	9.40	9.40	0.53	0.35	0.18	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	27.06	15.86	19.74	13.31	0.44	0.22	0.22	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	48.45	14.59	10.51	6.42	0.00	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	22.26	17.32	14.91	19.16	0.57	0.23	0.00	0.11
Mast cell, expanded, donor8	11941-126A6	21.42	34.81	14.90	14.06	0.84	0.00	0.84	0.00
Melanocyte - dark, donor1	11502-119F8	22.39	2.49	2.69	1.39	0.10	0.10	0.20	0.20
Melanocyte - dark, donor2	11582-120F7	13.15	0.69	2.08	3.81	0.69	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	17.39	1.45	5.14	6.88	0.22	0.29	0.29	0.14
Melanocyte - light, donor1	11274-116H5	4.23	1.18	2.59	1.65	0.00	0.00	0.24	0.00
Melanocyte - light, donor2	11351-117H1	3.41	0.00	3.41	1.36	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	4.34	0.00	4.34	1.73	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	23.01	1.87	6.66	5.00	0.00	0.10	0.10	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	20.44	5.65	4.30	6.72	0.54	0.27	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	12.32	0.80	5.36	5.89	0.00	0.00	0.00	0.27
Meningeal Cells, donor1	11493-119E8	17.12	1.12	0.99	2.11	0.12	0.12	0.00	0.00
Meningeal Cells, donor2	11573-120E7	19.81	1.32	0.44	2.64	0.00	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	24.86	1.39	1.39	2.53	0.08	0.00	0.00	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	22.81	0.57	1.14	2.28	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	14.99	0.60	2.42	4.93	0.30	0.00	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	0.00	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	14.35	0.72	0.00	2.87	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	7.20	1.48	3.18	6.56	0.85	0.21	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	6.03	3.02	3.52	1.51	0.00	0.50	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	9.23	0.22	0.66	0.66	0.00	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	10.96	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	8.80	0.20	0.41	0.20	0.20	0.00	0.00	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	5.82	0.55	0.55	6.79	0.14	0.00	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	1.86	0.00	0.37	0.74	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	9.08	1.45	3.55	5.00	0.13	0.13	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	3.56	0.00	0.30	0.59	0.00	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	7.68	0.00	1.28	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	18.08	0.35	2.48	0.71	0.35	0.00	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	9.38	0.94	3.13	3.44	0.00	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	27.58	1.45	0.73	2.18	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	9.02	1.86	7.16	7.16	0.00	0.27	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	6.51	3.50	6.01	9.51	0.00	0.00	1.50	0.50
Mesothelial Cells, donor3	11402-118D7	13.01	2.75	5.13	4.05	0.36	0.00	0.07	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	5.40	136.38	31.06	4.05	1.35	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	6.40	106.64	35.46	13.55	1.97	0.99	1.72	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	2.65	75.68	31.21	8.83	2.94	0.29	1.18	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	124.45	34.57	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	4.03	82.76	26.97	11.78	1.86	0.62	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	2.70	57.46	28.00	8.71	0.83	1.87	0.83	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	122.75	16.21	0.00	4.63	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	2.25	66.07	29.28	11.01	1.50	1.25	1.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	2.33	107.53	33.51	8.38	0.93	0.47	2.33	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	291.99	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	3.66	58.32	29.47	11.38	2.44	0.61	0.81	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	1.19	76.02	24.95	8.32	0.40	1.19	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	239.44	17.10	0.00	0.00	0.00	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	53.98	20.35	4.42	1.77	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	1.90	62.69	23.94	11.78	2.66	1.14	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	161.86	17.11	2.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	3.82	74.70	26.53	12.31	1.27	0.85	1.27	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	88.40	23.02	3.68	0.00	0.00	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	5.37	78.09	27.12	8.05	1.19	0.89	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	134.13	18.44	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	237.65	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	5.27	65.23	22.58	8.53	1.51	1.00	1.76	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	1.66	64.41	26.86	9.74	0.71	0.71	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.98	133.24	21.56	1.11	0.55	0.55	1.66	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	3.91	46.05	24.41	10.36	2.30	0.69	1.15	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	2.31	49.64	30.08	6.31	1.26	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	3.47	61.76	27.11	6.52	1.02	0.61	0.82	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	4.51	51.92	23.60	9.65	1.50	0.64	0.86	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	1.33	63.35	26.90	3.33	0.89	0.89	1.11	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	82.55	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	3.94	49.28	21.68	4.82	0.66	0.44	0.66	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.03	81.11	25.85	7.60	0.00	0.51	1.52	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	137.53	23.20	4.97	0.00	0.00	1.66	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.07	71.75	31.26	5.44	0.82	0.27	0.82	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.71	63.82	28.23	6.47	1.76	0.29	1.47	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	95.95	21.81	1.09	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.61	41.33	18.26	4.81	1.92	0.48	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.40	67.64	24.01	4.80	0.40	0.40	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	74.05	31.54	4.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.01	46.55	23.53	6.51	2.00	0.50	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	215.58	26.95	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	46.89	18.35	2.04	0.00	0.00	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.95	54.74	25.84	10.95	3.07	1.75	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	134.65	17.66	1.10	0.00	0.00	3.31	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.89	94.78	26.26	1.28	1.28	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	10.91	45.87	30.99	12.64	1.74	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.26	98.82	36.88	9.05	2.78	0.00	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	121.54	26.52	6.63	0.00	4.42	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	6.50	48.20	30.77	13.68	1.03	1.71	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.81	136.54	31.07	7.44	3.50	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.17	85.22	23.44	5.33	1.07	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	8.70	58.64	36.19	14.87	2.81	0.56	1.40	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2.91	140.48	39.90	8.31	3.74	1.25	1.25	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.83	118.88	41.37	6.99	1.75	0.58	2.33	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.33	64.25	31.98	13.27	1.81	1.21	1.51	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	3.76	111.44	37.15	15.44	5.01	0.00	1.67	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	144.38	21.66	7.22	0.00	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	7.39	89.58	20.32	13.85	3.69	1.85	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1.71	140.00	41.55	18.21	6.26	1.14	1.71	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	7.19	63.56	28.19	7.60	2.07	0.69	0.14	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	6.22	46.39	29.28	15.55	3.37	1.55	0.78	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.01	135.13	34.75	12.01	4.72	0.43	1.72	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	7.62	100.36	27.31	3.81	1.27	0.00	1.91	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.41	71.53	27.49	8.81	2.40	1.33	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	6.29	99.98	35.32	15.27	4.19	0.90	2.69	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	4.24	53.11	26.13	6.22	0.99	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	4.46	45.55	28.35	8.60	3.82	1.27	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.08	105.48	33.83	18.80	4.20	1.77	1.55	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.13	89.87	30.72	6.07	1.14	0.76	2.65	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	7.10	52.28	29.55	13.07	2.27	0.85	1.70	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	4.42	83.82	28.51	16.96	4.67	1.72	1.23	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	3.26	87.32	29.33	2.61	0.00	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.35	67.63	22.35	8.82	2.35	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	4.61	100.91	32.87	10.38	3.75	0.58	1.15	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	7.42	88.61	36.68	10.30	1.24	0.41	1.24	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	3.28	61.34	27.69	7.15	1.79	0.60	1.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	116.77	11.30	18.83	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	60.60	26.73	7.13	3.56	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	8.87	112.04	33.84	13.14	1.31	0.00	2.63	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	3.16	110.45	32.61	18.94	1.05	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	6.52	112.68	26.29	18.19	2.77	0.20	1.78	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	2.79	123.87	38.18	15.83	1.86	0.93	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	10.51	122.05	29.29	20.28	1.50	0.38	2.25	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	2.40	64.99	30.90	10.12	0.80	0.00	0.80	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	6.22	103.26	39.47	20.02	2.71	0.79	1.36	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	7.37	77.36	28.73	15.47	1.47	0.00	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	11.36	121.65	28.95	16.86	3.30	0.00	1.83	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	119.78	43.56	17.11	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	11.76	168.88	58.79	34.74	4.28	1.60	3.21	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	88.87	19.32	11.59	7.73	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	12.12	121.19	27.27	16.16	4.04	1.01	3.03	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.48	138.72	47.65	13.49	3.37	0.42	3.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	10.90	175.69	43.58	14.98	8.17	0.00	4.09	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	12.08	118.26	62.94	36.24	5.72	0.00	1.27	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	14.58	153.87	84.22	46.97	4.86	0.81	2.43	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	116.30	45.31	16.61	6.04	0.00	3.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	51.39	11.42	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	29.36	45.67	13.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	57.03	28.51	14.26	0.00	4.75	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	25.10	12.55	0.00	0.00	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	9.48	1.08	3.66	4.31	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	9.93	1.57	1.57	2.61	0.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	20.69	1.33	2.67	3.34	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	26.29	2.92	2.50	3.76	0.42	0.00	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	22.44	1.90	4.94	4.37	0.57	0.19	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	70.22	4.79	1.60	1.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	21.76	0.00	2.72	2.04	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	51.45	0.00	11.03	5.51	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	13.39	1.67	2.93	6.28	0.84	0.00	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	20.92	1.63	3.25	4.18	0.46	0.00	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	16.21	3.24	3.78	2.43	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	17.24	9.46	3.99	6.94	1.05	0.00	0.42	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	11.13	11.13	22.27	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	11.42	1.49	1.99	4.47	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	4.87	1.89	5.41	6.50	0.54	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.97	2.27	2.04	6.12	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.61	3.27	3.10	3.10	0.65	0.00	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	11.48	6.01	2.37	8.20	0.91	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	8.49	6.90	1.59	7.43	1.59	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	3.00	0.00	0.60	0.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	12.14	2.30	7.55	9.52	0.33	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.99	1.46	2.60	3.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	20.81	11.82	4.41	7.94	0.71	0.00	0.71	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	14.06	2.11	5.63	2.11	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.11	2.30	1.84	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.64	3.21	2.57	2.57	0.00	0.00	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	9.31	3.45	5.52	7.59	1.03	0.00	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	53.10	10.11	15.17	32.87	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	29.85	10.03	5.35	5.79	1.34	0.22	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	16.09	10.16	2.54	8.04	2.96	0.00	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.07	0.95	1.66	3.09	0.47	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	13.31	3.86	2.15	4.72	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	0.00	18.06	27.08	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.00	0.67	1.67	2.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	36.07	10.37	1.80	3.61	0.45	0.00	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.89	5.56	1.19	2.78	1.59	0.00	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.00	2.79	1.86	3.71	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	12.11	1.51	3.41	1.89	0.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	11.41	1.63	0.65	3.58	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	11.33	2.61	2.18	1.74	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	28.95	6.78	4.52	5.43	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.05	0.88	2.65	7.06	0.88	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	10.64	0.00	1.33	4.65	0.66	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	8.93	0.50	2.48	1.98	0.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	10.72	2.30	0.38	1.91	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	11.19	0.60	3.02	3.63	0.30	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	18.57	2.43	2.65	3.98	0.44	0.00	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	9.49	2.71	2.03	2.71	2.71	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	10.22	5.11	20.44	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.02	1.22	1.22	4.88	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	10.39	0.31	1.26	1.57	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	11.50	2.42	0.91	1.82	0.00	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.87	1.58	3.96	6.33	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	9.07	3.40	4.53	6.80	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	10.12	15.17	45.52	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	13.29	0.75	2.24	2.86	0.50	0.12	0.12	0.00
Myoblast, donor2	11322-117D8	16.88	1.34	3.84	3.26	0.19	0.19	0.19	0.00
Myoblast, donor3	11398-118D3	20.18	1.85	3.70	4.71	0.17	0.34	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	101.42	154.11	154.83	79.39	9.34	10.65	4.52	0.29
Natural Killer Cells, donor1	11230-116C6	19.99	86.72	71.65	12.61	1.54	7.69	4.00	0.00
Natural Killer Cells, donor2	11311-117C6	23.82	86.55	62.72	9.35	0.60	4.82	3.02	0.30
Natural Killer Cells, donor3	11387-118C1	21.53	84.30	74.17	8.28	0.92	6.26	2.02	0.00
Neural stem cells, donor1	11275-116H6	72.59	1.09	2.18	8.71	0.00	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	98.21	0.00	13.48	26.96	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	67.14	3.41	6.83	15.93	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	77.06	6.60	12.55	17.39	1.54	0.44	0.22	1.10
Neurons, donor3	11655-122E8	84.68	4.93	4.93	13.98	0.00	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	25.06	971.62	316.45	22.27	6.50	20.42	28.77	0.00
Neutrophils, donor2	11314-117C9	20.29	843.57	286.99	20.29	26.09	5.80	23.19	2.90
Neutrophils, donor3	11390-118C4	76.97	1933.93	519.83	40.32	25.66	26.27	62.31	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	12.11	0.24	1.90	4.16	0.00	0.00	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	11.40	0.33	0.33	2.60	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	13.84	0.40	1.00	4.21	0.00	0.00	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	8.53	2.06	3.44	2.20	0.28	0.00	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	11.87	2.17	3.18	3.62	0.00	0.00	0.00	0.14
Olfactory epithelial cells, donor3	11935-125I9	11.35	1.93	2.84	3.29	0.11	0.11	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	13.93	0.78	2.34	3.41	0.10	0.19	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	22.87	4.81	10.83	7.82	0.00	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	8.72	0.43	0.43	3.83	0.00	0.00	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	6.86	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.34	0.62	1.86	3.72	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	8.01	0.59	0.39	1.76	0.39	0.20	0.00	0.20
Osteoblast, donor2	11354-117H4	33.71	1.40	2.81	3.51	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	26.84	2.31	3.91	2.49	0.18	0.18	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	15.08	0.84	2.19	3.96	0.25	0.00	0.00	0.08
Pericytes, donor1	11491-119E6	2.00	0.00	0.45	1.11	0.00	0.00	0.00	0.11
Pericytes, donor2	11571-120E5	3.85	0.68	0.45	2.04	0.45	0.00	0.00	0.23
Pericytes, donor3	11652-122E5	7.32	1.63	2.03	0.81	0.00	0.00	0.00	0.20
Perineurial Cells, donor1	11499-119F5	15.71	0.79	2.60	4.41	0.11	0.11	0.00	0.11
Perineurial Cells, donor2	11579-120F4	18.40	1.93	3.04	4.88	0.18	0.09	0.09	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	18.17	126.86	62.47	11.16	3.19	2.55	3.19	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	12.49	155.98	59.01	8.82	1.22	1.22	2.94	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	16.18	102.63	58.37	6.86	1.16	2.07	2.98	0.26
Placental Epithelial Cells, donor1	11278-116H9	10.52	4.07	2.63	9.33	2.15	0.24	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	2.22	0.00	3.33	7.76	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	6.09	2.16	1.96	7.46	0.20	0.59	0.20	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.23	0.63	0.63	1.58	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	6.94	1.31	0.75	2.63	0.00	0.38	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	6.40	1.44	2.35	3.26	0.13	0.39	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	7.66	0.23	2.48	1.58	0.23	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	7.25	1.70	1.60	3.09	0.11	0.11	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	6.55	0.44	3.06	2.18	0.00	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	10.46	0.86	3.01	3.29	0.14	0.14	0.29	0.00
Preadipocyte - perirenal, donor1	11469-119C2	5.91	0.98	1.97	0.00	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	9.52	1.23	0.31	0.92	0.31	0.00	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	27.27	1.06	1.59	3.01	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	10.22	0.68	1.53	2.55	0.17	0.00	0.00	0.34
Preadipocyte - visceral, donor1	11280-116I2	25.71	0.93	1.30	3.91	0.09	0.00	0.00	0.00
Preadipocyte - visceral, donor2	11357-117H7	21.63	1.38	3.22	2.30	0.00	0.00	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	17.35	0.94	0.52	1.46	0.10	0.00	0.00	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	21.42	2.87	7.24	7.24	0.15	0.60	0.00	0.15
Prostate Epithelial Cells, donor2	11331-117E8	17.87	11.65	7.85	7.04	0.81	0.54	0.54	0.14
Prostate Epithelial Cells, donor3	11404-118D9	18.19	2.69	6.61	4.10	0.12	0.18	0.18	0.00
Prostate Stromal Cells, donor1	11254-116F3	19.59	1.82	2.16	2.39	0.00	0.00	0.00	0.11
Prostate Stromal Cells, donor2	11332-117E9	23.31	1.79	1.61	1.97	0.00	0.00	0.18	0.00
Prostate Stromal Cells, donor3	11405-118E1	6.36	1.04	2.40	3.44	0.21	0.10	0.00	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.04	1.46	4.38	1.46	0.36	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	37.36	5.75	12.68	6.10	0.14	0.62	0.00	0.00
Renal Epithelial Cells, donor1	11517-119H5	10.14	0.00	1.52	0.51	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	8.54	0.71	2.85	1.42	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	37.37	3.60	14.61	6.14	0.21	0.42	0.11	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	5.45	6.81	0.68	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	9.84	6.74	1.62	0.40	0.00	0.00	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	43.96	7.99	5.33	3.77	0.89	0.44	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	0.67	0.67	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	9.02	0.44	2.64	1.10	0.22	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	12.54	1.25	5.02	2.51	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.61	0.55	2.77	0.28	0.00	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	28.72	3.22	7.52	1.07	0.27	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	15.60	1.27	3.37	1.27	0.84	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	17.74	1.54	6.36	1.35	0.58	0.39	0.19	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	46.15	0.26	4.67	5.96	0.00	0.00	0.00	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	13.64	0.85	2.56	3.41	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	0.00	1.03	0.00	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	24.34	0.50	3.76	7.28	0.00	0.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	25.12	22.85	12.03	2.94	0.67	0.40	0.40	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	92.02	4.47	8.04	17.87	0.89	0.89	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	47.33	1.10	3.30	24.77	1.10	1.10	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	95.13	2.90	7.54	23.78	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	107.79	13.26	8.45	30.69	1.95	0.39	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	102.78	7.55	15.00	17.87	1.29	0.10	0.30	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	123.59	8.25	19.18	27.77	0.89	0.33	0.45	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	106.43	6.95	16.75	35.10	0.74	1.12	0.25	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	100.46	7.23	13.40	20.28	0.93	0.47	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	119.03	10.17	20.34	24.96	0.92	0.92	0.23	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	81.87	8.35	8.76	20.26	0.14	0.82	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	92.13	8.47	13.92	19.06	1.66	0.45	0.15	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	130.63	7.17	19.71	25.80	1.79	0.54	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	83.78	9.47	9.61	23.96	0.86	0.57	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	94.97	8.05	16.85	18.35	0.97	0.54	0.43	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	102.89	5.53	13.05	22.35	1.11	0.44	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	88.13	6.69	7.84	18.93	1.15	0.76	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	103.22	7.92	14.53	18.54	0.75	0.47	0.09	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	134.17	10.33	18.79	28.00	1.50	0.94	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	110.94	10.35	9.02	21.37	1.46	0.40	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	102.99	7.69	17.81	17.03	1.07	0.49	0.39	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	109.42	8.02	19.48	25.21	0.95	0.57	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	98.46	12.28	8.86	19.97	0.96	0.53	0.11	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	96.14	8.69	11.77	16.82	0.56	0.28	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	117.75	7.52	17.94	21.36	1.03	0.68	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	103.56	10.39	11.67	18.05	1.46	0.00	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	100.07	8.83	16.43	21.34	1.10	0.61	0.25	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	108.53	9.81	18.67	23.64	1.75	0.67	0.00	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	82.79	9.91	6.13	26.42	1.89	0.71	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	103.77	7.54	18.45	19.05	1.19	0.40	0.20	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	119.96	9.59	21.75	25.72	0.94	0.47	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	74.65	10.58	8.50	21.56	0.21	0.62	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	127.42	12.83	17.25	21.24	1.33	0.00	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	113.63	12.53	18.38	20.26	1.67	0.21	0.21	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	94.48	12.38	10.36	19.92	0.81	0.27	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	138.45	10.39	16.69	14.82	0.85	0.51	0.00	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	137.08	11.37	22.36	21.79	1.35	0.39	0.39	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	94.22	10.83	8.08	20.80	1.38	0.86	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	124.82	14.27	19.89	18.65	1.10	0.27	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	118.86	12.97	18.22	24.13	1.15	0.33	0.33	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	85.22	6.14	10.40	21.30	1.19	1.02	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	114.08	6.81	16.57	22.64	0.89	0.59	0.15	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	111.95	8.80	13.86	21.32	0.53	0.80	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	74.11	4.98	4.84	19.63	0.28	0.41	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	94.53	5.48	14.52	22.14	1.43	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	129.99	5.64	18.34	22.37	1.01	0.20	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	63.10	3.58	6.03	18.74	0.57	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	70.57	5.59	10.83	22.01	0.35	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	77.97	3.02	8.16	14.81	1.51	0.00	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	70.37	2.94	5.26	18.73	0.61	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	157.49	7.57	24.45	38.86	1.60	0.29	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	59.02	6.08	16.43	17.04	1.22	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	75.35	2.41	5.73	20.50	0.30	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	64.01	3.17	12.89	14.48	1.13	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	82.37	2.10	13.48	16.47	1.20	0.00	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	60.10	4.25	6.38	21.37	1.06	0.94	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	65.31	3.20	11.53	16.86	0.21	0.21	0.00	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	97.36	3.00	13.82	19.23	0.60	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	7.71	0.94	0.75	1.13	0.19	0.00	0.00	0.56
Schwann Cells, donor2	11578-120F3	37.43	0.00	6.80	0.00	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	15.55	2.41	2.41	3.94	0.22	0.22	0.00	0.22
Sebocyte, donor1	11220-116B5	14.24	6.57	6.03	5.48	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	16.54	5.97	8.73	3.22	1.38	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	9.07	1.65	1.44	1.65	0.00	0.41	0.00	0.21
Sertoli Cells, donor1	11255-116F4	14.91	0.00	6.63	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	0.00	0.00	0.00	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	20.23	0.62	2.02	3.61	0.09	0.18	0.09	0.26
Skeletal Muscle Cells, donor2	11358-117H8	8.67	0.72	0.72	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	22.57	2.51	5.02	0.84	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	24.98	0.31	1.41	2.98	0.31	0.16	0.00	0.16
Skeletal Muscle Cells, donor5	11455-119A6	27.05	1.78	1.78	4.01	0.15	0.15	0.00	0.45
Skeletal Muscle Cells, donor6	11459-119B1	30.16	1.69	1.69	4.92	0.46	0.31	0.00	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	18.40	1.01	1.51	2.65	0.25	0.13	0.00	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.26	0.43	1.71	2.00	0.29	0.00	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	37.20	3.47	3.27	3.47	0.40	0.10	0.30	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	23.17	2.61	2.53	5.81	0.67	0.17	0.08	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	14.48	0.72	0.00	0.72	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.81	1.10	0.96	1.51	0.00	0.00	0.00	0.14
Skin - palm, donor1	10286-104F7	72.52	5.37	5.37	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	15.28	13.84	4.76	3.46	0.86	0.14	0.14	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	67.07	58.89	15.54	16.36	4.09	0.82	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	20.51	9.35	5.06	3.25	0.26	0.52	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	22.10	10.70	12.65	7.37	0.83	0.42	0.28	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	17.02	7.74	10.69	1.55	0.84	0.28	0.42	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	66.61	19.45	24.10	14.17	0.21	1.06	0.63	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	21.21	5.17	9.97	2.85	0.37	0.22	0.30	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	13.27	0.62	0.93	0.62	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	8.00	0.67	1.11	4.89	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	15.87	0.59	0.00	1.76	0.00	0.00	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	12.60	0.44	0.22	1.77	0.22	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.48	1.18	0.39	1.18	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	12.36	0.00	1.55	3.09	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	4.00	2.00	0.00	6.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	10.91	1.06	2.93	1.60	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	9.97	0.44	0.44	2.22	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	24.20	3.84	2.69	3.58	0.00	0.64	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	16.28	1.95	2.93	9.44	0.33	0.00	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	14.47	1.48	2.66	4.73	0.30	0.30	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	9.11	2.28	4.27	5.13	0.14	0.14	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	3.09	0.16	0.49	0.98	0.16	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	13.40	0.00	0.61	2.44	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	5.81	0.25	1.26	1.52	0.00	0.00	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	6.12	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.63	1.91	0.48	1.43	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	11.65	1.33	1.92	5.31	0.15	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	12.27	1.72	1.72	3.23	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	16.90	0.84	3.25	4.41	0.21	0.00	0.10	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	9.74	0.77	1.24	1.55	0.15	0.00	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	0.00	0.00	3.23	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	14.94	0.90	0.30	2.39	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.41	0.34	0.68	0.34	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	13.82	1.18	2.36	4.08	0.08	0.00	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	13.18	1.01	2.92	2.62	0.00	0.10	0.00	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	13.20	0.91	2.28	1.37	0.23	0.00	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	4.83	0.00	0.60	3.02	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	47.95	0.79	1.85	2.38	0.26	0.00	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	11.85	1.46	1.60	1.46	0.13	0.27	0.00	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	12.27	1.13	1.75	3.88	0.00	0.00	0.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.83	0.76	1.52	1.78	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	17.64	1.66	2.71	3.77	0.60	0.00	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.00	0.75	0.75	0.00	0.00	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	20.68	2.58	3.88	14.21	0.00	0.00	0.00	6.46
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	11.63	0.00	0.93	2.79	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	11.61	1.01	1.51	0.50	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	10.66	0.63	2.51	0.63	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.47	0.59	0.88	1.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	32.16	1.08	1.67	3.42	0.08	0.00	0.00	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	6.07	0.93	2.80	2.80	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	14.54	1.73	2.88	1.87	0.14	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	18.36	5.10	5.10	1.53	0.00	0.25	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	11.28	0.00	1.32	1.32	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.56	1.40	1.96	5.87	0.00	0.42	0.14	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	17.26	1.59	3.18	5.61	0.17	0.08	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.38	0.00	0.00	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	12.48	0.73	1.96	3.67	0.00	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	11.49	2.43	1.77	3.98	0.00	0.22	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	15.51	0.88	0.59	2.05	0.29	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	4.08	0.19	0.00	0.78	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.99	1.06	1.85	2.38	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	3.72	0.00	1.12	4.46	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	6.47	1.44	1.08	4.67	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.38	0.57	0.57	1.14	0.57	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	20.09	0.79	1.18	3.15	0.00	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.13	0.00	0.76	5.08	0.00	0.25	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	5.59	0.40	0.80	4.79	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	7.11	0.00	0.42	4.18	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	5.50	0.92	0.00	3.67	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	14.64	0.50	2.19	1.51	0.00	0.00	0.00	0.00
Synoviocyte, donor2	11368-117I9	7.71	1.01	1.84	1.84	0.00	0.00	0.00	0.00
Synoviocyte, donor3	11440-118H9	8.71	0.45	0.67	1.79	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	9.65	1.07	1.07	1.43	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.57	1.16	0.93	0.69	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	21.43	4.16	5.66	5.02	0.22	0.36	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	16.24	5.41	6.19	1.55	0.00	0.39	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	14.32	3.44	4.01	1.15	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	28.42	21.90	10.83	3.32	0.49	0.49	0.98	0.12
Urethra, donor2	10319-105A4	37.77	21.58	16.19	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	4.78	0.80	3.72	0.80	0.00	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	4.81	0.40	3.61	0.40	0.40	0.40	0.00	0.40
Urothelial Cells, donor3	11681-122H7	5.04	0.46	2.98	0.46	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	18.95	2.01	12.93	6.91	0.45	0.45	1.11	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	5.34	245.58	78.30	6.23	2.67	5.34	5.34	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	8.58	238.75	85.78	11.44	10.01	7.15	4.29	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	3.42	199.88	81.46	8.90	2.74	2.05	6.16	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	10.33	149.10	85.74	8.61	2.07	3.10	4.82	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	7.55	203.36	94.71	11.62	6.39	3.49	5.23	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	8.33	235.32	65.60	7.29	2.08	9.37	5.21	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	8.26	223.02	57.82	15.60	0.00	8.26	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	8.22	188.06	90.38	0.91	4.56	5.48	6.39	0.00
Wilms' tumor cell line:G-401	10809-111A8	57.61	5.06	8.02	7.03	1.36	0.49	0.00	0.12
Wilms' tumor cell line:HFWT	10597-108E3	59.84	1.76	5.28	0.88	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	137.98	47.48	26.26	28.77	2.23	1.68	0.28	0.28
achilles tendon, donor2	10292-104G4	28.93	59.93	28.93	0.00	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	63.48	20.91	29.57	7.65	1.27	1.02	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	93.57	18.81	16.72	13.23	0.93	0.46	1.16	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	140.43	25.05	24.10	7.72	0.83	1.66	1.19	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	140.68	28.57	17.42	12.79	1.09	1.09	1.36	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	284.74	96.41	17.43	7.87	2.25	1.97	2.25	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	61.12	64.50	19.67	9.31	1.48	1.48	1.27	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	57.44	66.96	17.15	3.81	1.09	1.09	1.09	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	150.70	92.97	17.18	25.12	3.53	0.00	1.32	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	78.00	11.84	5.31	2.04	0.41	0.41	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	71.06	116.49	59.41	21.74	3.11	0.78	2.33	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	32.57	20.42	8.28	1.84	0.37	0.18	0.74	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	81.91	93.61	31.20	27.30	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	144.08	45.55	16.27	12.32	2.32	2.56	1.16	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	111.33	103.82	35.47	29.26	7.25	1.29	0.52	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	101.12	132.97	42.08	23.67	2.92	1.46	0.58	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	108.29	138.96	54.84	9.30	1.86	0.46	0.93	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	62.10	44.83	37.84	6.17	0.41	0.00	0.82	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	108.05	136.90	17.80	3.99	2.46	0.00	3.38	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	86.20	79.37	42.67	12.80	1.71	0.85	3.41	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	68.54	75.52	47.31	11.53	1.82	1.21	3.03	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	97.25	73.66	47.18	10.59	2.17	0.72	3.13	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	101.12	126.07	22.27	18.93	4.01	0.67	1.56	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	107.74	1.00	5.34	3.34	0.33	0.67	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	395.80	18.58	20.44	3.72	1.86	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	156.69	0.00	0.00	0.00	0.00	0.00	0.00	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	122.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	119.97	0.00	1.87	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	66.65	3.77	20.02	8.48	0.00	0.24	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	16.91	43.43	13.19	7.14	1.71	0.47	1.40	0.16
adipose, donor1	10184-103D4	159.50	1.17	7.62	15.25	0.59	0.59	0.00	0.00
adipose, donor2	10185-103D5	55.56	0.41	3.65	4.46	0.00	0.00	0.00	0.41
adipose, donor3	10186-103D6	65.08	2.18	3.81	4.90	5.17	0.00	0.00	0.00
adipose, donor4	10187-103D7	69.34	6.93	7.80	6.07	13.00	0.00	0.00	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	104.32	1.74	4.26	4.10	0.16	0.32	0.16	0.63
adrenal gland, adult, pool1	10081-102A9	21.83	7.28	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	57.76	0.40	1.07	0.00	0.00	0.00	0.00	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	47.52	2.50	6.43	7.86	0.36	0.00	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	26.66	6.26	9.97	15.53	1.85	0.70	0.00	0.93
amniotic membrane cells, donor2	12236-129G4	30.43	10.48	12.85	30.09	2.37	1.35	0.00	1.69
amniotic membrane cells, donor3	12237-129G5	27.99	7.37	7.37	25.92	1.47	1.47	0.00	0.00
amygdala - adult, donor10196	10167-103B5	39.13	13.04	17.79	26.09	0.00	2.37	1.19	0.00
amygdala, adult, donor10252	10151-102I7	36.90	34.47	23.52	10.54	1.01	0.41	1.22	0.61
amygdala, newborn, donor10223	10360-105E9	28.73	22.92	13.23	17.75	0.32	0.32	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	26.87	0.64	4.46	6.11	0.13	0.00	0.00	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	131.71	2.21	4.41	4.63	0.22	0.44	0.22	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	79.17	0.33	3.67	9.02	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	18.24	13.53	4.71	1.37	0.00	0.39	0.59	0.20
appendix, adult	10189-103D9	39.59	93.92	42.69	6.60	2.72	0.78	4.66	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	26.48	0.00	7.22	1.38	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	17.66	2.72	4.08	2.72	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	99.96	9.13	26.37	23.32	1.45	1.59	0.00	0.29
b cell line:RPMI1788	10427-106D4	42.38	1.78	2.68	1.04	0.15	0.15	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	11.38	2.22	3.88	4.44	0.00	0.28	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	40.68	8.04	12.90	9.03	0.69	0.60	0.10	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	11.55	5.52	16.07	7.20	0.84	1.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	35.79	80.53	46.98	21.81	1.12	1.12	3.36	0.00
bladder, adult, pool1	10011-101C2	14.12	10.86	6.95	1.63	0.33	0.33	0.22	0.00
blood, adult, pool1	10053-101G8	8.86	117.38	64.22	2.21	2.21	4.43	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	19.70	0.00	2.57	2.57	0.86	0.00	0.86	0.00
bone marrow, adult	10192-103E3	16.20	64.11	14.85	11.47	0.67	0.67	0.67	0.67
brain, adult, donor1	10084-102B3	48.18	25.63	18.45	16.40	3.08	1.03	0.00	1.03
brain, adult, pool1	10012-101C3	38.20	26.17	27.39	33.18	2.78	1.56	0.45	0.67
brain, fetal, pool1	10085-102B4	53.43	16.03	21.37	48.09	0.00	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	52.20	54.84	26.10	17.84	3.63	0.33	0.99	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	66.91	10.24	13.23	8.74	0.50	0.37	0.12	0.87
breast, adult, donor1	10080-102A8	25.25	29.67	15.15	6.94	0.00	0.63	1.26	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	55.52	10.42	17.91	14.48	1.91	0.89	0.38	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	128.02	16.39	27.83	18.24	2.78	0.62	0.62	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	65.84	0.46	2.53	2.30	0.00	0.23	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	68.75	6.78	8.23	11.14	1.45	0.48	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	69.58	0.94	3.76	6.11	0.00	1.41	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	75.47	8.09	10.50	7.11	0.55	0.66	0.33	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	70.98	0.32	3.49	8.87	0.32	0.00	0.95	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	83.58	1.33	3.73	9.05	0.00	0.00	0.00	0.80
caudate nucleus - adult, donor10196	10177-103C6	78.29	40.30	29.93	24.18	0.00	5.76	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	53.21	37.82	37.31	14.22	1.34	1.84	2.84	0.67
caudate nucleus, adult, donor10258	10379-105H1	76.41	36.68	44.32	21.40	3.82	4.58	2.29	0.76
caudate nucleus, newborn, donor10223	10354-105E3	51.27	38.82	16.85	27.47	2.20	1.46	1.83	0.73
cerebellum - adult, donor10196	10173-103C2	90.31	14.57	17.48	37.87	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	104.41	7.26	17.08	19.22	0.64	0.85	0.21	0.64
cerebellum, adult, pool1	10083-102B2	57.95	9.31	13.45	23.46	0.69	1.72	0.34	0.69
cerebellum, newborn, donor10223	10357-105E6	88.84	16.61	11.62	19.10	0.83	0.00	0.00	0.83
cerebral meninges, adult	10188-103D8	35.55	24.96	28.24	18.91	1.01	1.51	0.25	0.50
cerebrospinal fluid, donor2	10294-104G6	31.43	46.78	19.00	3.65	0.73	1.46	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	27.75	1.15	4.03	13.37	0.14	0.14	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	35.96	23.86	18.56	17.73	2.15	1.49	0.50	0.00
cervix, adult, pool1	10013-101C4	21.63	8.19	3.78	1.78	0.21	0.21	0.42	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	23.83	0.84	5.02	4.32	0.28	0.42	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	30.04	5.23	13.06	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	96.19	2.73	12.92	4.72	0.50	0.87	0.00	0.37
choriocarcinoma cell line:SCH	10785-110H2	104.73	5.42	16.39	19.96	2.83	1.60	0.12	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	51.94	0.71	4.98	0.95	0.24	0.71	0.00	0.47
chorionic membrane cells, donor1	12238-129G6	27.07	3.99	7.12	7.69	0.28	0.28	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	16.21	3.88	8.75	3.68	0.60	0.20	0.50	0.10
chorionic membrane cells, donor3	12240-129G8	42.31	5.49	4.95	3.30	0.00	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	80.78	40.39	13.13	7.07	2.02	3.03	2.02	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	178.27	36.11	17.29	11.33	0.58	0.38	1.73	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	133.05	32.95	16.47	6.76	1.06	0.00	0.63	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	57.78	1.03	10.02	10.27	0.00	0.51	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	54.18	2.66	14.27	13.30	0.24	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	58.84	3.26	11.61	9.57	0.81	0.81	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	88.04	2.65	10.01	14.43	0.88	0.29	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	196.51	11.47	7.56	7.82	0.26	0.00	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	61.49	2.06	10.97	8.00	0.46	0.23	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	55.35	4.51	14.40	13.71	0.87	0.17	0.35	0.00
colon carcinoma cell line:CACO-2	10513-107D9	49.79	4.39	6.59	5.67	0.18	0.73	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	72.22	1.14	5.32	11.40	0.00	0.00	0.00	0.76
colon, adult, donor1	10082-102B1	26.18	16.66	11.90	3.57	0.00	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	33.84	11.63	8.58	2.12	0.24	0.12	0.24	0.00
colon, fetal, donor1	10070-101I7	31.52	19.78	9.89	1.24	0.00	0.62	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	307.10	64.17	55.00	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	80.74	2.97	8.50	0.85	0.85	0.85	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	73.35	3.17	11.77	2.41	0.15	0.60	0.00	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	74.17	6.49	14.10	3.81	0.42	1.41	0.00	0.28
corpus callosum, adult, pool1	10042-101F6	43.12	30.96	19.13	33.61	2.99	0.66	0.88	1.00
cruciate ligament, donor2	10295-104G7	17.83	39.71	18.64	5.67	0.81	0.00	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	27.29	14.45	4.82	3.21	0.00	0.00	0.00	0.80
diencephalon, adult	10193-103E4	40.80	26.40	13.44	30.24	1.44	1.92	1.20	1.92
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	50.51	8.04	13.55	5.05	0.00	0.92	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	106.68	18.46	13.85	16.93	1.28	0.77	1.28	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	42.61	0.96	5.06	5.78	0.24	0.24	0.00	0.00
ductus deferens, adult	10196-103E7	23.42	3.49	6.48	0.50	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	31.69	34.57	10.08	2.88	0.00	0.00	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	48.55	27.95	6.62	2.94	0.00	1.47	1.47	0.00
dura mater, adult, donor1	10041-101F5	14.12	82.17	20.65	9.91	3.22	0.25	2.64	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	42.64	1.33	1.11	0.22	0.22	0.00	0.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	74.08	2.58	3.73	1.43	0.29	0.00	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	93.73	1.85	14.18	4.32	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	69.32	0.91	6.96	4.24	0.61	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	86.45	1.54	11.11	7.10	0.00	0.62	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	97.20	1.31	5.25	5.25	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	83.46	2.35	3.69	6.70	0.34	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	38.78	1.27	10.33	7.97	0.18	0.36	0.36	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	34.09	8.68	10.45	8.68	0.96	0.32	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	89.37	23.57	23.68	18.90	1.00	1.11	0.33	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	83.37	12.32	19.80	15.40	0.88	0.55	0.22	0.22
epididymis, adult	10197-103E8	19.47	18.21	5.23	5.65	0.00	0.42	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	48.61	0.00	0.53	0.35	0.00	0.00	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	60.17	0.39	1.97	0.79	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	44.69	4.72	10.22	7.47	0.92	0.39	0.00	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	39.96	2.95	10.92	7.68	0.79	0.39	0.10	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	47.28	6.16	11.65	7.73	0.67	0.90	0.56	0.22
esophagus, adult, pool1	10015-101C6	22.40	8.07	9.98	4.14	0.21	0.32	0.00	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	64.50	2.38	9.27	12.15	0.50	0.50	0.13	0.25
eye - muscle inferior rectus, donor1	10272-104E2	45.88	4.83	2.41	7.24	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	44.19	33.67	10.52	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	34.23	11.91	0.00	1.49	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	37.83	19.49	6.88	0.00	0.00	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	40.81	34.98	17.49	8.74	1.46	0.00	2.91	0.00
eye, fetal, donor1	10054-101G9	27.20	7.37	6.86	4.58	0.00	0.25	0.76	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	41.42	2.95	6.28	6.15	0.13	0.38	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	73.84	1.66	2.85	2.61	0.24	0.00	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	46.26	16.70	35.56	43.35	2.53	2.91	0.84	1.13
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	70.86	11.11	19.22	18.62	1.20	0.30	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	48.28	4.39	17.56	11.34	0.18	0.46	0.09	0.00
gall bladder, adult	10198-103E9	11.35	14.73	5.79	1.21	0.48	0.48	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	8.05	98.78	70.33	15.57	2.68	8.05	8.59	0.00
gamma delta positive T cells, donor2	11938-126A3	7.10	177.03	61.63	17.55	2.61	7.10	4.48	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	50.48	7.82	9.72	17.53	0.00	0.63	0.63	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	31.14	1.55	5.61	6.38	0.39	0.00	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	75.58	1.64	6.39	6.56	1.15	0.00	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	66.81	0.00	6.41	9.15	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	36.55	0.91	2.51	1.14	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	65.40	2.29	11.70	5.62	0.00	0.46	0.11	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	100.07	2.38	11.34	12.88	0.00	0.00	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	37.91	5.99	10.48	9.73	1.00	0.50	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	25.86	4.01	4.43	11.08	0.95	0.32	0.11	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	37.50	3.93	6.88	9.41	0.70	0.28	0.14	0.14
glioblastoma cell line:T98G	10485-107A8	38.63	4.75	9.38	13.24	1.10	0.11	0.11	0.11
glioma cell line:GI-1	10413-106B8	32.51	1.46	12.59	16.11	0.88	0.29	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	69.25	36.45	30.61	29.16	4.37	1.46	0.73	1.46
globus pallidus, adult, donor10252	10161-103A8	47.35	92.76	37.83	21.97	1.95	0.98	3.91	2.20
globus pallidus, adult, donor10258	10367-105F7	36.97	20.54	23.28	12.32	1.37	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	48.50	33.57	10.13	20.25	1.07	0.53	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	208.01	308.34	80.76	7.34	0.00	0.00	7.34	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	65.57	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	57.49	20.91	26.13	5.23	0.00	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	27.84	2.24	5.44	4.48	0.00	0.32	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	58.77	3.21	2.75	4.13	0.92	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	48.47	1.83	1.83	5.49	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	46.37	3.86	1.29	5.15	0.00	0.00	0.00	1.29
hIPS, biol_rep1	14380-156B6	73.30	12.94	2.87	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	52.13	4.80	0.69	8.92	0.69	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	39.72	29.79	6.62	28.69	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	47.99	3.45	3.45	1.44	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	23.92	8.97	3.59	1.79	0.30	0.30	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	19.87	5.75	4.45	3.66	0.00	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	39.97	15.82	8.33	0.83	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	35.51	10.20	6.53	3.26	0.41	0.41	0.20	0.20
heart, adult, diseased, donor1	10051-101G6	6.81	6.81	6.81	2.98	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	20.70	16.33	8.74	2.99	0.00	0.00	0.00	0.23
heart, fetal, pool1	10046-101G1	26.39	10.47	12.83	4.83	0.51	0.51	0.41	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	9.87	1.23	6.17	4.63	0.31	0.00	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	127.24	15.46	16.65	4.76	0.00	0.00	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	53.15	0.77	4.09	1.88	0.00	0.22	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	53.28	0.73	4.61	1.46	0.24	0.12	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	53.66	0.81	3.94	2.53	0.10	0.30	0.00	0.00
hepatoma cell line:Li-7	10484-107A7	32.70	7.34	17.13	17.24	1.11	0.89	0.22	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	80.60	10.35	16.98	9.05	0.80	0.60	0.20	0.10
hippocampus - adult, donor10196	10169-103B7	41.64	41.64	12.30	23.66	1.89	1.89	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	39.80	36.94	20.82	12.65	0.61	0.20	1.02	0.82
hippocampus, adult, donor10258	10374-105G5	39.84	14.94	15.44	32.37	2.49	1.00	0.50	1.00
hippocampus, newborn, donor10223	10363-105F3	34.19	14.45	8.46	16.57	0.70	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	122.68	9.16	9.16	6.71	1.22	1.83	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	79.33	6.28	5.50	3.93	0.59	0.98	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	94.70	4.82	7.11	4.57	1.02	0.51	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	77.81	1.13	2.82	3.95	0.00	0.56	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	80.82	1.81	3.36	3.61	0.00	0.52	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	77.44	0.76	1.52	3.80	0.00	0.00	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	72.40	0.88	6.13	6.13	0.88	0.58	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	69.58	1.51	2.37	5.60	0.22	0.00	0.22	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	69.65	1.67	2.09	7.09	0.42	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	82.40	1.42	3.79	4.74	0.47	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	70.23	1.45	2.25	3.54	0.48	0.00	0.00	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	87.53	2.02	4.04	5.39	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	62.12	2.82	3.60	5.79	0.31	0.16	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	63.38	3.93	2.46	5.90	0.49	0.49	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	80.29	4.36	7.85	7.85	0.00	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	87.44	1.15	4.39	5.35	0.19	0.57	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	83.73	1.31	2.62	8.72	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	85.96	1.00	5.00	6.50	0.50	0.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	48.04	0.94	2.26	6.59	0.19	0.19	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	51.84	0.45	2.73	5.91	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	45.42	0.31	2.19	7.83	1.57	0.00	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	44.42	1.96	1.47	6.21	0.00	0.33	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	47.61	1.16	0.87	3.19	0.58	0.00	0.00	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	53.81	1.20	1.20	4.48	0.90	0.30	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	61.70	4.43	4.62	6.84	1.29	0.18	0.18	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	63.05	5.42	6.28	4.85	0.57	0.57	0.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	83.30	7.76	6.12	5.31	2.04	0.41	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	76.40	1.76	7.39	4.58	0.70	0.70	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	65.88	2.53	2.85	7.29	0.63	0.32	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	83.22	1.51	4.24	4.84	0.30	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	50.68	0.52	2.07	5.69	1.03	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	37.86	1.99	2.66	9.30	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	54.38	0.51	2.05	5.39	0.51	0.51	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	49.85	1.28	5.11	6.65	0.00	0.26	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	60.58	2.27	1.51	3.79	0.00	0.00	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	58.81	2.69	3.36	5.71	0.00	0.34	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	61.83	3.14	5.31	6.04	0.97	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	64.17	5.35	3.12	4.46	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	72.20	2.93	3.90	5.85	0.98	0.49	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	81.60	1.53	3.36	6.42	0.61	0.00	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	276.53	3.25	19.52	52.05	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	92.33	0.99	3.97	3.97	0.33	0.66	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	62.39	0.55	3.28	3.28	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	56.09	1.45	1.09	7.60	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	57.65	0.71	1.07	4.27	0.00	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	62.06	2.39	0.00	3.58	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	73.27	1.90	2.30	6.23	0.54	0.14	0.14	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	59.54	0.81	1.62	3.23	0.00	0.00	0.00	0.27
immature langerhans cells, donor1	11904-125F5	27.36	115.99	41.65	6.78	2.42	1.21	0.24	0.00
immature langerhans cells, donor2	11905-125F6	24.56	48.32	23.76	7.92	0.79	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	49.78	16.56	31.61	39.08	3.41	1.80	1.14	1.14
keratoacanthoma cell line:HKA-1	10791-110H8	36.09	26.34	34.47	23.74	0.98	0.65	0.98	0.98
kidney, adult, pool1	10017-101C8	27.03	12.42	9.91	4.81	0.30	0.30	0.30	0.00
kidney, fetal, pool1	10045-101F9	25.68	3.96	4.95	2.62	0.07	0.35	0.35	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	146.28	6.82	11.50	13.49	1.14	0.14	0.14	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	12.03	0.69	3.18	4.29	0.00	0.41	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	29.36	3.85	4.22	6.61	0.55	0.55	0.37	0.00
left atrium, adult, donor1	10079-102A7	10.90	28.88	5.99	2.72	1.09	0.00	1.09	0.54
left ventricle, adult, donor1	10078-102A6	11.63	23.26	9.10	5.06	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	78.80	1.09	1.64	4.65	0.00	0.00	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	3.95	0.00	1.80	2.16	0.00	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	11.41	1.63	2.17	5.43	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	8.98	0.97	0.73	2.67	0.00	0.00	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	35.55	4.18	18.82	8.36	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	171.77	18.77	26.56	14.17	0.83	0.71	0.47	0.47
liposarcoma cell line:KMLS-1	10782-110G8	12.65	0.94	4.84	3.91	0.00	0.31	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	44.71	4.63	8.16	6.21	0.61	0.24	0.12	0.12
liver, adult, pool1	10018-101C9	21.72	8.91	3.08	0.65	0.16	0.16	0.00	0.00
liver, fetal, pool1	10086-102B5	20.70	5.64	2.82	0.00	0.00	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	47.10	34.12	18.37	31.35	2.48	1.31	1.17	0.44
locus coeruleus, adult, donor10252	10165-103B3	29.90	38.39	15.32	21.41	1.85	0.37	1.29	0.18
locus coeruleus, adult, donor10258	10375-105G6	29.34	20.88	7.05	23.14	1.13	0.28	0.28	0.56
locus coeruleus, newborn, donor10223	10362-105F2	34.49	34.49	7.15	20.61	2.10	2.10	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	22.42	9.13	15.36	9.13	0.55	0.42	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	53.08	22.75	13.79	17.92	0.69	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	58.79	15.03	32.03	7.25	0.53	0.40	0.92	0.13
lung, adult, pool1	10019-101D1	17.01	35.08	20.20	4.73	0.35	0.47	0.71	0.00
lung, fetal, donor1	10068-101I5	51.66	40.24	6.56	5.99	0.57	0.57	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	23.83	68.73	21.99	2.29	0.46	1.83	0.46	0.00
lymph node, adult, donor1	10077-102A5	9.47	119.29	34.56	3.79	1.89	0.95	1.89	0.00
lymphangiectasia cell line:DS-1	10727-110A7	48.00	30.03	16.22	20.38	1.75	1.75	1.75	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	55.24	50.41	45.28	8.75	1.06	2.11	0.60	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	77.30	27.18	9.34	11.89	2.55	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	63.05	12.43	19.09	22.20	2.66	0.89	0.89	0.89
mature adipocyte, donor2	12232-129F9	58.11	8.51	11.62	14.53	1.45	0.42	0.62	1.45
mature adipocyte, donor3	12233-129G1	46.70	9.96	16.83	22.05	4.03	0.95	0.71	0.71
mature adipocyte, donor4	12234-129G2	45.80	5.79	11.58	22.64	0.53	0.26	0.53	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	46.94	2.14	5.72	11.44	0.71	0.24	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	40.61	15.79	25.94	42.87	2.26	2.26	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	41.20	36.41	37.15	32.92	1.47	1.66	1.47	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	38.44	16.84	20.01	40.66	1.91	1.59	0.64	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	43.50	25.59	39.24	43.50	3.84	1.71	0.00	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	57.71	33.24	45.39	39.66	2.70	3.54	0.68	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	43.72	42.23	42.23	25.68	2.76	0.85	1.49	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	26.97	23.12	19.26	30.82	0.00	1.93	0.00	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	0.00	57.41	43.06	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	39.12	20.82	23.33	28.00	2.87	1.08	0.00	1.08
medulla oblongata - adult, donor10196	10174-103C3	36.34	25.31	7.79	21.42	0.00	0.65	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	29.41	47.68	24.46	20.90	2.48	0.31	2.32	1.08
medulla oblongata, adult, pool1	10038-101F2	35.51	27.75	13.22	27.18	2.20	0.90	0.65	0.57
medulla oblongata, newborn, donor10223	10361-105F1	35.41	35.76	6.60	6.94	0.69	0.00	2.78	0.00
medulloblastoma cell line:D283 Med	10838-111E1	77.72	0.44	1.11	4.21	0.00	0.00	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	88.16	28.73	19.56	21.76	2.08	1.22	0.37	0.00
melanoma cell line:COLO 679	10514-107E1	39.67	2.87	7.47	8.48	1.01	0.29	0.14	0.00
melanoma cell line:G-361	10465-106H6	21.17	3.26	7.06	9.23	0.81	0.54	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	30.57	1.81	8.86	3.26	0.00	0.18	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	120.72	2.64	11.46	18.50	0.88	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	172.12	5.44	6.48	14.00	0.78	0.52	0.00	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	10.59	0.77	0.77	2.30	0.00	0.15	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	6.91	0.18	0.55	2.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	4.56	0.83	0.83	2.07	0.00	0.00	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	7.73	0.00	1.26	1.69	0.00	0.00	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	6.93	0.00	2.70	3.47	0.00	0.00	0.00	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.72	0.69	1.39	2.08	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	5.49	0.34	2.57	2.06	0.00	0.34	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	6.79	0.46	1.50	2.99	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.72	0.93	1.86	3.85	0.00	0.00	0.00	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	19.85	1.35	1.76	3.78	0.00	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	18.07	1.85	3.41	3.56	0.00	0.00	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	6.59	0.66	2.63	1.32	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	15.64	1.38	2.08	4.98	0.28	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	14.66	0.35	1.05	2.79	0.00	0.00	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	6.53	0.41	2.65	3.06	0.61	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	8.99	0.72	2.16	1.08	0.36	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.14	0.52	3.41	4.45	0.00	0.10	0.10	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.75	1.82	2.96	4.56	0.23	0.23	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	25.59	2.10	2.52	7.55	0.42	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	9.56	0.75	1.79	3.74	0.45	0.30	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	12.87	0.88	5.95	4.29	0.09	0.09	0.00	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	7.73	0.00	3.68	3.68	0.00	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	11.73	2.00	2.58	4.58	0.00	0.00	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	37.89	8.84	7.58	12.63	2.11	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.96	0.91	2.74	1.83	0.00	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.72	0.26	1.53	2.05	0.26	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	8.38	1.05	1.57	3.93	0.00	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	9.86	0.00	0.92	3.70	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	10.83	0.94	0.71	2.35	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	7.11	0.00	1.02	1.35	0.00	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.43	1.18	1.18	2.36	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	9.27	0.46	0.46	3.24	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	10.67	0.87	1.44	2.31	0.29	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	9.37	1.34	1.34	2.23	0.00	0.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	7.93	1.44	1.44	2.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	16.87	1.47	0.00	5.13	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	10.07	0.67	0.67	2.35	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	10.23	0.41	1.23	2.87	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.45	0.00	0.43	0.43	0.00	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	2.73	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	12.67	1.30	1.30	2.27	0.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	13.09	2.91	1.45	1.45	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	11.19	2.13	0.53	1.07	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	12.27	0.82	0.82	3.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	11.27	0.78	0.78	1.17	0.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	4.97	0.00	0.99	1.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	0.00	0.00	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	10.08	1.19	1.19	2.37	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.77	0.00	0.00	1.90	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.55	0.69	0.69	2.07	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	0.00	2.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	0.00	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	5.30	0.00	0.00	2.04	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	6.36	1.59	0.00	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	6.48	0.00	0.59	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.79	0.00	0.62	0.31	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	5.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	22.47	0.00	4.73	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	0.00	0.00	7.70	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	13.77	0.69	2.07	2.75	0.00	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	45.03	1.48	1.48	7.92	0.49	0.00	0.00	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	25.79	2.24	0.00	5.61	0.00	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	49.61	2.54	1.91	8.27	0.00	0.64	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	68.51	3.22	4.03	10.07	0.40	0.40	0.00	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	76.32	4.36	2.18	2.18	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	48.15	2.53	1.27	10.14	0.00	0.00	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	33.38	0.61	3.64	12.14	1.21	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	0.00	4.52	18.08	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	32.12	0.00	4.94	6.59	1.65	0.00	0.00	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	21.03	2.98	0.99	6.94	1.39	0.00	0.40	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	19.15	1.30	0.65	6.49	0.65	0.32	0.00	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	15.28	2.04	0.00	6.11	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	58.59	6.14	22.21	27.40	1.42	0.00	0.24	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	33.59	12.28	12.05	16.22	1.39	0.23	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	8.55	0.00	4.27	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	31.13	5.96	6.17	9.04	0.41	0.00	0.21	0.10
mesothelioma cell line:Mero-25	10850-111F4	26.78	4.99	3.40	3.86	0.68	0.45	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	34.96	4.89	7.09	9.29	0.49	0.49	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	28.12	3.10	7.09	10.19	0.22	0.22	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	48.36	3.94	7.10	8.41	0.26	0.53	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	29.11	8.00	7.83	9.19	0.68	0.51	0.34	0.17
mesothelioma cell line:Mero-84	10855-111F9	43.73	12.64	6.07	9.35	3.03	1.52	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	34.99	4.76	7.04	12.42	0.41	0.21	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	77.03	4.14	4.97	6.96	0.50	0.00	0.00	0.50
mesothelioma cell line:NCI-H226	10846-111E9	37.47	15.75	7.24	7.78	2.53	0.54	0.72	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	26.14	4.95	5.12	7.86	1.02	1.02	0.00	0.17
mesothelioma cell line:NCI-H28	10845-111E8	49.62	12.21	14.50	15.27	2.04	0.76	0.51	0.51
mesothelioma cell line:No36	10857-111G2	42.41	8.81	5.55	4.89	0.33	0.33	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	38.20	2.44	5.69	7.59	0.54	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	17.66	34.35	45.68	18.23	2.69	1.15	0.77	0.00
migratory langerhans cells, donor2	11902-125F3	14.41	39.81	41.03	19.17	2.32	1.10	0.98	0.00
migratory langerhans cells, donor3	11903-125F4	13.46	65.87	42.00	29.08	2.33	1.62	0.36	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	62.68	3.59	12.73	14.04	0.33	0.33	0.33	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	47.05	3.81	9.33	8.48	1.27	0.42	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	94.68	28.56	25.34	14.74	1.61	0.23	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	41.86	2.09	7.42	0.57	0.19	0.00	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	191.26	110.14	80.57	53.59	2.59	2.96	4.44	0.55
myeloma cell line:PCM6	10474-106I6	61.67	34.99	34.99	17.99	2.37	2.17	1.58	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	56.82	5.07	8.12	3.55	0.00	0.51	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	66.30	0.39	1.96	0.59	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	26.18	3.23	5.35	4.23	0.33	0.33	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	23.39	3.46	6.62	5.37	0.51	0.66	0.22	0.07
nasal epithelial cells, donor2	12227-129F4	24.29	3.86	6.07	5.52	1.10	0.00	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	70.40	0.46	2.76	12.88	0.23	0.23	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	69.03	0.56	3.93	8.98	0.56	0.00	0.37	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	66.64	0.42	2.74	8.01	0.42	0.00	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	101.19	5.03	6.89	31.49	1.49	0.75	0.19	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	46.73	0.47	0.00	5.22	0.24	0.00	0.00	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	56.54	4.12	3.48	10.14	0.32	0.48	0.32	1.58
neuroectodermal tumor cell line:TASK1	10774-110F9	135.65	1.01	4.83	5.64	0.20	0.00	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	199.63	5.72	3.81	8.90	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	16.77	1.86	3.73	2.13	0.00	0.27	0.00	0.00
neutrophil PMN, donor1	12133-128D9	59.50	922.24	371.87	0.00	0.00	14.87	29.75	0.00
neutrophil PMN, donor2	12137-128E4	13.28	332.02	146.09	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	255.71	132.59	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	69.85	16.91	24.86	12.18	1.01	1.18	0.34	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	118.48	8.81	28.82	30.42	1.60	3.20	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	16.35	1.60	0.64	4.49	0.00	0.00	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	11.56	2.10	3.15	3.15	0.00	0.26	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	49.31	18.47	33.93	35.81	1.97	2.34	1.31	1.03
occipital cortex - adult, donor10196	10172-103C1	43.27	20.60	41.21	32.97	4.12	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	46.96	53.14	46.43	23.08	3.49	0.81	3.22	1.61
occipital cortex, newborn, donor10223	10355-105E4	39.67	25.11	40.03	31.30	2.91	1.46	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	38.31	41.72	43.82	49.07	2.62	2.62	0.79	1.05
occipital lobe, fetal, donor1	10073-102A1	130.88	11.59	24.46	61.79	2.57	0.86	1.29	0.86
occipital pole, adult, pool1	10036-101E9	27.20	12.22	26.57	29.09	1.26	2.05	0.47	0.47
olfactory region, adult	10195-103E6	38.21	13.56	23.31	24.65	1.72	0.96	1.34	0.96
optic nerve, donor1	10277-104E7	92.05	36.02	16.01	40.02	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	52.74	2.85	20.62	10.14	0.23	0.80	0.11	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	122.96	21.84	35.86	40.94	1.79	1.79	0.41	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	34.37	4.23	6.60	5.25	0.34	0.17	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	61.22	2.43	11.20	7.74	0.23	0.46	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	17.64	2.06	2.65	0.88	0.00	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	113.99	9.34	9.34	4.67	0.00	0.93	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	19.30	3.61	3.82	5.51	0.21	0.00	0.00	0.85
ovary, adult, pool1	10020-101D2	17.30	11.97	3.06	1.66	0.09	0.00	0.26	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	53.71	5.13	5.87	2.38	0.18	0.37	0.00	0.00
pancreas, adult, donor1	10049-101G4	27.28	6.58	2.82	0.94	0.00	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	127.47	5.03	12.02	3.91	0.84	1.40	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	48.04	9.88	11.07	3.41	0.68	0.68	0.51	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	48.68	8.11	13.41	10.27	0.17	1.49	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	36.97	16.66	32.49	46.95	2.47	1.46	0.92	0.64
parietal cortex, adult, donor10258	10373-105G4	34.50	22.02	15.41	36.70	4.40	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	51.73	21.63	31.04	31.98	2.82	2.82	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	35.63	31.64	47.60	32.21	1.71	0.86	2.28	0.86
parietal lobe, adult, pool1	10034-101E7	34.45	12.51	28.46	38.33	2.56	2.29	0.44	0.88
parietal lobe, fetal, donor1	10072-101I9	158.08	12.61	27.16	42.67	3.88	2.91	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	44.49	19.44	18.69	29.53	3.74	1.12	0.37	1.12
parotid gland, adult	10199-103F1	24.67	8.63	8.63	0.62	0.00	0.62	0.00	0.00
penis, adult	10200-103F2	18.80	10.74	4.83	1.61	0.00	0.00	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	115.47	0.93	0.93	6.69	0.00	0.37	0.00	1.86
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	40.79	16.75	19.09	7.87	0.58	0.44	0.29	0.00
pineal gland - adult, donor10196	10179-103C8	39.99	7.74	1.94	1.29	0.00	0.65	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	70.47	24.28	13.62	7.70	1.18	0.59	1.78	0.59
pineal gland, adult, donor10258	10377-105G8	25.71	8.78	7.52	4.39	0.00	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	67.79	8.09	9.11	7.08	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	98.50	26.06	21.89	20.33	0.52	1.04	0.00	1.04
pituitary gland, adult, donor10258	10378-105G9	64.69	9.36	11.92	11.92	0.85	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	36.55	14.94	8.28	2.58	0.22	0.00	0.65	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	73.10	10.59	16.16	14.57	0.79	1.59	0.13	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.61	2.96	5.91	7.78	0.47	0.16	0.31	0.31
pons, adult, pool1	10033-101E6	33.05	16.87	20.40	44.32	2.93	1.20	0.69	0.69
postcentral gyrus, adult, pool1	10032-101E5	30.77	15.95	30.51	39.58	2.35	1.92	0.78	0.70
promyelocytes/myelocytes PMC, donor1	12132-128D8	294.89	131.76	31.37	0.00	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	55.08	16.52	33.05	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	58.68	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	65.55	1.89	16.31	9.18	0.73	0.44	0.15	0.00
prostate cancer cell line:PC-3	10439-106E7	261.36	50.64	36.66	25.59	4.36	1.63	1.09	1.27
prostate, adult, pool1	10022-101D4	17.23	10.79	4.44	1.81	0.45	0.09	0.27	0.00
putamen, adult, donor10196	10176-103C5	68.69	33.76	58.07	20.77	0.71	3.07	2.36	1.18
putamen, adult, donor10252	10152-102I8	68.63	92.15	43.14	17.65	3.92	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	48.08	18.58	9.84	15.30	4.37	1.09	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	54.60	26.09	35.03	27.30	3.38	7.73	0.48	0.72
putamen, newborn, donor10223	10365-105F5	40.48	23.24	8.25	29.24	2.25	4.50	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	64.88	3.20	13.09	6.69	0.00	0.29	0.00	0.00
rectum, fetal, donor1	10067-101I4	70.94	61.20	6.95	2.78	0.00	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	28.41	2.12	3.60	4.66	0.00	0.21	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	25.68	0.83	5.80	2.49	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	29.32	11.33	4.47	4.97	0.60	0.20	0.30	0.50
retinoblastoma cell line:Y79	10475-106I7	50.66	2.08	5.98	13.25	0.26	0.78	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	61.11	0.61	2.58	0.74	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	323.38	1.41	4.22	5.34	0.00	0.28	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	20.46	1.52	3.03	1.52	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	16.51	3.40	9.06	9.55	0.32	0.16	0.00	0.00
salivary acinar cells, donor2	11772-123I8	17.90	1.93	3.99	7.85	0.28	0.14	0.00	0.14
salivary acinar cells, donor3	11773-123I9	27.81	3.31	3.97	7.28	0.00	0.00	0.00	1.32
salivary gland, adult, pool1	10093-102C3	16.59	13.73	4.58	2.86	0.57	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	27.32	1.52	8.68	7.34	0.08	0.25	0.08	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	25.39	0.94	9.99	8.11	0.24	0.00	0.00	0.12
seminal vesicle, adult	10201-103F3	33.86	9.52	2.12	0.00	0.00	0.53	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	47.13	12.15	12.88	20.16	1.46	0.97	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	17.61	2.01	6.29	5.54	0.50	0.50	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	34.12	2.01	9.03	13.05	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	67.16	8.19	17.86	6.72	1.07	1.61	0.67	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	38.02	17.02	12.27	11.94	0.88	0.77	0.33	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	24.77	3.35	6.19	1.94	0.13	0.26	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	57.46	9.93	10.64	5.67	1.42	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	31.54	7.20	6.72	3.72	0.60	0.36	0.24	0.36
skeletal muscle, fetal, donor1	10066-101I3	55.28	11.06	5.03	2.01	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	46.08	7.57	10.10	6.94	0.00	0.00	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	58.70	3.00	3.00	2.33	0.67	0.33	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	104.02	3.47	9.46	16.39	0.63	0.32	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	80.57	0.39	4.63	6.17	0.00	0.00	0.00	2.12
small cell lung carcinoma cell line:LK-2	10541-107H1	123.29	7.75	9.23	12.36	0.82	0.49	0.16	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	89.75	1.13	3.06	9.33	0.00	0.00	0.00	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	56.88	1.96	3.70	5.23	0.00	0.00	0.00	0.00
small intestine, adult, pool1	10024-101D6	71.31	15.05	11.59	5.49	1.07	0.36	0.24	0.36
small intestine, fetal, donor1	10064-101I1	53.56	28.50	8.85	7.13	1.23	0.25	0.25	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	32.83	2.56	5.64	2.05	0.00	0.51	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	13.44	4.91	4.39	2.33	0.26	0.26	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	42.62	3.75	11.52	6.70	0.00	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	63.09	57.12	23.40	30.05	2.52	0.69	1.61	0.69
spinal cord, adult, donor10252	10159-103A6	29.96	94.23	26.02	20.50	1.58	0.79	1.58	0.39
spinal cord, adult, donor10258	10369-105F9	28.36	32.51	8.99	26.98	2.77	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	62.20	23.78	14.64	15.86	1.22	1.22	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	42.25	75.77	16.07	14.24	0.92	0.00	1.84	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	19.12	1.79	3.88	2.09	0.00	0.00	0.00	0.00
spleen, adult, pool1	10025-101D7	20.60	72.36	38.44	7.05	1.54	1.98	2.64	0.11
spleen, fetal, pool1	10044-101F8	18.43	47.36	25.66	6.36	0.79	1.51	2.38	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	43.89	14.08	21.63	7.87	0.41	0.93	0.31	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	78.23	10.25	18.04	14.81	0.57	0.57	0.19	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	62.20	5.24	11.18	7.34	0.00	0.00	0.70	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	72.71	10.56	12.90	5.86	1.17	1.56	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	39.40	3.60	9.00	7.77	0.68	0.56	0.00	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	74.55	17.37	21.60	24.99	2.12	1.27	0.00	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	64.73	2.54	11.00	3.81	0.00	0.42	0.00	0.85
stomach, fetal, donor1	10062-101H8	59.81	19.22	19.22	1.07	0.00	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	25.07	15.95	8.55	2.28	0.00	0.57	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	108.55	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	28.66	51.30	23.68	22.64	1.45	0.62	2.91	1.66
substantia nigra, adult, donor10258	10371-105G2	32.59	23.28	6.72	23.79	2.59	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	35.33	48.75	4.95	14.84	2.12	0.71	2.83	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	65.34	1.60	8.25	10.78	0.92	0.23	0.23	0.23
temporal lobe, adult, pool1	10031-101E4	26.87	12.21	24.50	24.75	1.61	0.76	0.68	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	124.65	7.12	27.78	34.19	2.85	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	72.08	7.03	10.11	34.28	0.88	0.00	0.00	2.20
tenocyte, donor1	11763-123H8	10.47	0.35	1.75	3.14	0.00	0.00	0.00	0.35
tenocyte, donor2	11765-123I1	6.87	0.00	0.38	1.14	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	6.30	1.11	1.11	2.97	0.00	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	92.63	1.87	4.93	2.21	0.00	0.17	0.17	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	69.52	0.15	0.77	0.31	0.15	0.00	0.00	0.15
teratocarcinoma cell line:PA-1	10807-111A6	117.01	1.70	3.41	4.03	0.00	0.31	0.00	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	107.78	18.79	24.37	7.11	0.63	1.52	0.76	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	50.30	3.03	1.51	1.51	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	59.66	3.60	3.60	3.05	0.22	0.76	0.11	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	118.88	5.21	7.49	2.93	0.33	0.33	0.00	0.98
testis, adult, pool1	10026-101D8	67.75	11.06	5.91	1.93	0.11	0.54	0.11	0.54
testis, adult, pool2	10096-102C6	104.20	3.61	1.35	2.26	0.45	0.00	0.00	0.90
thalamus - adult, donor10196	10168-103B6	51.89	30.91	18.77	41.95	2.21	0.00	2.21	0.00
thalamus, adult, donor10252	10154-103A1	39.85	55.64	27.66	16.57	0.94	1.09	1.72	2.03
thalamus, adult, donor10258, tech_rep1	10370-105G1	29.25	50.81	7.70	36.95	3.08	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	25.20	22.89	9.88	23.06	1.65	1.81	0.16	0.33
thalamus, newborn, donor10223	10366-105F6	36.25	12.66	10.36	18.99	2.30	0.58	0.58	0.00
throat, adult	10209-103G2	24.72	18.23	7.74	5.24	0.00	0.00	0.50	0.25
throat, fetal, donor1	10061-101H7	44.49	12.19	11.58	5.48	1.22	0.30	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	48.69	0.40	0.40	1.79	0.00	0.00	0.00	0.60
thymus, adult, pool1	10027-101D9	52.29	53.78	29.73	12.92	2.58	1.19	1.69	0.30
thymus, fetal, pool1	10043-101F7	47.48	45.93	37.09	12.99	1.66	2.49	1.66	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	79.64	5.32	18.48	10.24	0.66	0.40	0.00	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	50.29	3.49	6.29	6.29	0.56	0.28	0.14	0.42
thyroid, adult, pool1	10028-101E1	21.56	6.16	9.98	7.56	0.47	0.37	0.28	0.28
thyroid, fetal, donor1	10060-101H6	38.23	11.86	13.71	13.45	1.85	0.26	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	43.11	9.24	9.24	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	25.82	10.23	7.21	1.86	0.23	0.47	0.00	0.00
tongue, fetal, donor1	10059-101H5	36.26	12.61	6.70	3.55	0.39	0.00	1.18	0.39
tonsil, adult, pool1	10047-101G2	25.75	28.55	39.17	6.71	1.50	1.10	1.30	0.10
trachea, adult, pool1	10029-101E2	21.92	24.38	13.50	3.52	0.98	0.33	0.57	0.33
trachea, fetal, donor1	10058-101H4	18.85	10.77	7.31	2.69	0.00	0.77	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	27.28	1.77	2.48	0.35	0.35	0.00	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	60.99	9.83	16.92	16.11	1.52	1.11	0.20	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	65.03	0.47	10.18	9.87	0.47	0.47	0.00	0.47
tridermal teratoma cell line:HGRT	10694-109G1	38.05	1.90	0.00	5.71	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	32.68	2.62	5.42	5.93	0.25	0.08	0.34	0.08
umbilical cord, fetal, donor1	10057-101H3	16.69	6.26	6.26	2.09	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	22.01	6.14	4.61	2.73	0.00	0.17	0.17	0.34
uterus, fetal, donor1	10055-101H1	31.74	11.77	5.12	2.56	0.51	0.00	1.02	0.00
vagina, adult	10204-103F6	15.51	12.28	6.46	1.29	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	17.97	41.87	16.66	5.70	0.22	0.66	0.88	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	21.63	1.87	7.74	2.40	0.00	0.53	0.00	0.00

Property "Nearest transcripts" (as page type) with input value "ENST00000519824.6:59 ENST00000520254.5:73 NM_001353264.2:80 NM_001353244.2:80 NM_001353315.2:80 NM_001353296.2:80 NM_001353300.2:80 NM_001353268.2:80 NM_001353314.2:80 NM_001353299.2:80 NM_001256763.2:80 NM_001353295.2:80 NM_001353298.2:80 NM_001353301.2:80 NM_001353267.2:80 NM_001353265.2:80 NM_001353313.2:80 NM_016623.5:80 NM_001330612.2:80 NM_001353297.2:80 NM_001353266.2:80 ENST00000519070.5:85 ENST00000518344.1:120 ENST00000520204.5:128 AK130372:132 ENST00000522746.5:137 BC017297:137 MF125249:137 ENST00000522941.5:145 ENST00000522250.5:197 BC003599:240" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.